🏷

Classifications

ISDS Skeletal Nosology

👪

Inheritance

2

Autosomal dominant HP:0000006

Heterozygous p.Arg621His segregated in the founding Utah pedigree and was subsequently reported in an independent family; p.Arg621Cys was identified in an Italian father and daughter. The full penetrance reported in small ascertained families and assumed for the original linkage analysis is not a population penetrance estimate.

Autosomal dominant inheritance

Show evidence (2 references)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"we screened FGFR3 and subsequently identified a heterozygous missense mutation that is predicted to cause a p.R621H substitution in the tyrosine kinase domain and partial loss of FGFR3 function."

A heterozygous allele segregating through a multigeneration pedigree establishes dominant transmission.

PMID:27139183 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Our family confirms the consistent and unique phenotype of this condition, and the specificity of the mutation in FGFR3."

Independent 2016 family confirming the dominant phenotype; the small pedigree does not quantify population penetrance.

Autosomal recessive HP:0000007

Homozygous p.Thr546Lys was reported in two brothers of first-cousin parents with severe skeletal deformity. ClinGen describes subtle tall stature, relative microcephaly and long lower limbs in their parents and curates the broader gene-disease relationship as semidominant. Thus, the recessive presentation does not establish complete absence of effects in heterozygotes, nor does comparison with Arg621 families isolate an allele-dose effect.

Autosomal recessive inheritance

Show evidence (2 references)

PMID:24864036 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We report the phenotype and underlying molecular abnormality in two brothers, born to first cousin parents."

Affected sibs of consanguineous parents carrying the variant homozygously indicate recessive inheritance for this allele.

url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d SUPPORT DIRECT REVIEW SYNTHESIS Other

"Mother and father are mildly affected with slight tall stature, relative microcephaly, and long lower limbs."

ClinGen expert abstraction of the 2014 family qualifies the baseline claim that heterozygous parents were entirely unaffected.

?

Discussions and Knowledge Gaps

3

Which cranial developmental mechanisms explain human CATSHL findings, and how well do the mouse and zebrafish models capture them?

HUMAN MODEL MISMATCH catshl_craniofacial_model_mismatch

Attached to

phenotypes#Microcephaly phenotypes#High Palate phenotypes#Wormian Bones phenotypes#Intellectual Disability pathophysiology#Delayed Cranial Ossification

The 2020 study reports that the then-characterized Fgfr3-deficient mouse models lacked an apparent craniofacial skeletal phenotype, while its zebrafish model had cranial malformation and delayed sutural closure. Fish cartilage and osteoblast readouts support distinct developmental contributions, and Wnt inhibition partly improved cartilage but not intramembranous ossification. These findings do not establish the basis of human intellectual disability or prove that every mouse model lacks every cranial abnormality. Relative microcephaly in a very tall individual must also be distinguished from absolute microcephaly.

Show evidence (2 references)

PMID:32641982 SUPPORT DIRECT REVIEW SYNTHESIS Model Organism

"The reason for the discrepant in the craniofacial phenotypes between mouse model and patients remains to be studied."

The authors state the mismatch explicitly and record it as unresolved. Quoted as written, including the grammatical slip in the original.

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"craniofacial bone malformation with microcephaly and delayed closure of cranial sutures"

Establishes that the zebrafish, unlike the mouse, does show the craniofacial phenotype.

Do the Arg621 alleles act as dominant negatives, and if so does the mutant receptor actually inhibit its wild-type partner?

KNOWLEDGE GAP catshl_dominant_negative_untested

Attached to

pathophysiology#FGFR3 Kinase-Domain Loss of Function

The original Arg621His report inferred a dominant-negative mechanism from structural modeling, expression/localization observations and comparisons with null genotypes. It did not demonstrate mutant/wild-type heterodimer inhibition. ClinGen retains this as a proposed mechanism. Direct measurements of variant-specific kinase activity and signaling in relevant tissues are needed to distinguish hypomorphic, dominant-negative and context-dependent effects, including for the later candidate alleles.

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"For several reasons, it is unlikely that the loss of function caused by p.R621H results from haploinsufficiency."

The authors' own framing of the mechanism as an inference from exclusion rather than a demonstration.

Why does either too little or too much FGFR3 signaling cause deafness?

KNOWLEDGE GAP catshl_bidirectional_cochlear_failure

Attached to

pathophysiology#Failure of Cochlear Pillar Cell Differentiation

Loss of Fgfr3 abolishes pillar cell differentiation; the activating Y367C allele produces fully penetrant deafness with an increased number of pillar or modified supporting cells. The organ of Corti therefore fails in both directions from an intermediate optimum, which is unusual and is not explained by a simple dose-response model of the receptor. Whether the two deafnesses share a final common lesion or are distinct failures of the same patterning step is unknown, and the answer would constrain how the human hearing loss is expected to progress.

Show evidence (2 references)

PMID:19073250 SUPPORT DIRECT PRIMARY RESULT Model Organism

"The inner ear defect is mainly associated with an increased number of pillar cells or modified supporting cells in the organ of Corti."

Shows the gain-of-function receptor producing the opposite cellular change in the same structure, which is what makes the bidirectional failure a real question rather than a rhetorical one.

PMID:19073250 SUPPORT DIRECT PRIMARY RESULT Model Organism

"The mutant Fgfr3(Y367C/+) mice exhibit fully penetrant deafness with a significantly elevated auditory brainstem response threshold for all frequencies tested."

Establishes that the activating allele also causes deafness, not merely a cellular change.

⚙

Pathophysiology

15

FGFR3 Coding Missense Variation

Mechanism confidence: Established

Germline single-nucleotide substitutions alter the FGFR3 kinase-domain coding sequence. Classic pedigrees carry heterozygous Arg621His or Arg621Cys, or homozygous Thr546Lys. Additional missense variants in tall-stature or hearing-loss cohorts require individual interpretation.

FGFR3 hgnc:3690

Genetic context FGFR3 hgnc:3690 Variant type: single nucleotide variant Genomic context: coding sequence allele_type: MISSENSE variant_origin: GERMLINE

Zygosity varies by allele and family. A coding substitution is not itself proof of receptor loss of function.

Downstream

FGFR3 Kinase-Domain Loss of Function Allele-specific impairment is inferred; functional testing is required to distinguish partial loss from dominant-negative activity.

Show evidence (2 references)

PMID:37990933 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"molecular analysis revealed a hitherto unreported, monoallelic variant c.1861C>T (p.Arg621Cys) in FGFR3."

Direct identification of a coding substitution.

PMID:24864036 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Whole exome sequencing revealed a homozygous novel missense mutation in the FGFR3 gene in exon 12 (NM_000142.4:c.1637C>A: p.(Thr546Lys))."

Distinct homozygous coding substitution in the severe skeletal family.

FGFR3 Kinase-Domain Loss of Function

Mechanism confidence: Provisional

Reduced FGFR3 receptor signaling is inferred from the kinase-domain substitutions, structural modeling, segregation and the overlap with null-animal phenotypes. The Arg621His substitution may impair phosphate transfer, and a dominant-negative interaction with the wild-type receptor is proposed. Neither kinase inhibition by the human alleles nor mutant/wild-type heterodimer suppression was directly measured in the founding report. The direction of effect is supported by model systems and expert curation, while allele-specific biochemical mechanisms remain unresolved.

FGFR3 hgnc:3690 ⇓ LOSS OF FUNCTION

fibroblast growth factor receptor activity GO:0005007 ↓ DECREASED

Computational models

Arg621His kinase-domain homology model STRUCTURAL PREDICTION Structural modeling predicts interference with phosphate transfer.

Downstream

Reduced MAPK/ERK Output in Growth Plate Chondrocytes Receptor loss reduces growth-plate ERK activation in mouse experiments.

Increased Growth Plate Chondrocyte Proliferation Increased proliferation follows Fgfr3 loss; the complete downstream signaling route is unresolved.

Increased Chondrocyte Hypertrophy FGFR3 loss releases restraint on hypertrophic differentiation through multiple pathways.

Disordered Growth Plate Architecture Null cartilage has abnormal polarity and organization; intervening determinants remain incompletely mapped.

Reduced Hypertrophic Chondrocyte Apoptosis Conditional loss reduces hypertrophic-cell apoptosis in vivo, with no corresponding isolated-cell change.

Enhanced Canonical Wnt Signaling The fish signaling association is supported, but the intervening molecular route is unresolved.

Reduced Cranial Osteoblast Differentiation Reduced osteoblast maturation is demonstrated in the fish model; human relevance is provisional.

Failure of Cochlear Pillar Cell Differentiation FGFR3-dependent developmental signaling specifies pillar-cell fate.

Altered Cochlear Sensory Epithelial Patterning Loss of the receptor changes sensory epithelial cell-fate patterning in mice.

Show evidence (2 references)

PMID:17033969 SUPPORT INDIRECT PRIMARY RESULT Computational

"The p.R621H substitution may therefore interfere with the ability of FGFR3 to transfer phosphate to its peptide substrate, resulting in loss of function"

Homology-based mechanistic prediction, not a measured human-mutant kinase assay.

PMID:17033969 SUPPORT INDIRECT PRIMARY RESULT Human Clinical

"These observations suggest that p.R621H might, instead, cause loss of FGFR3 function by a dominant negative mechanism."

Author inference from expression/localization and comparisons with null genotypes; not direct evidence of inhibitory heterodimerization.

Reduced MAPK/ERK Output in Growth Plate Chondrocytes

Mechanism confidence: Provisional

Fgfr3-deficient mouse growth plates show reduced ERK phosphorylation, and isolated mutant chondrocytes respond less strongly to FGF18. Reduced MAPK output can release restraint on hypertrophic differentiation and increase Ihh expression. Increased proliferation after Fgfr3 loss is not assigned exclusively to ERK suppression, because ERK-specific perturbations can have different proliferation effects.

Growth plate chondrocyte CL:1000217

fibroblast growth factor receptor signaling pathway GO:0008543 ↓ DECREASED ERK1 and ERK2 cascade GO:0070371 ↓ DECREASED

Experimental models

Fgfr3-deficient primary mouse chondrocytes PRIMARY CELL CULTURE FGF18-induced ERK activation is reduced.

Downstream

Derepressed Indian Hedgehog Signaling MEK inhibition increases Ihh expression in primary chondrocytes.

Increased Chondrocyte Hypertrophy Reduced ERK signaling can release restraint on terminal chondrocyte differentiation.

Show evidence (2 references)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT In Vitro

"MAPK activation in response to FGF18 was also reduced in Fgfr3-deficient chondrocytes"

Direct primary-cell signaling result.

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"MAPK activity was reduced in hypertrophic zones of Fgfr3 cKO mice"

In vivo growth-plate ERK result; human CATSHL tissue was not assayed.

Derepressed Indian Hedgehog Signaling

Mechanism confidence: Provisional

IHH expression increases in Fgfr3-deficient mouse growth plates and zebrafish cranial skeleton. Mouse primary-cell experiments show that MEK inhibition can increase Ihh and Pthrp expression. Hedgehog inhibition prevents cartilage lesions in the conditional mouse model, supporting a causal contribution in that model; its contribution in patients is unmeasured.

smoothened signaling pathway GO:0007224 ↑ INCREASED

Experimental models

Fgfr3-deficient primary mouse chondrocytes PRIMARY CELL CULTURE Ihh/Pthrp expression rises after receptor deletion or MEK inhibition.

Animal models

Chondrocyte-specific postnatal Fgfr3 knockout mouse Mouse partially recapitulates The model is where the raised IHH and lowered ERK were actually measured.

fgfr3 knockout zebrafish Zebrafish partially recapitulates Head-skeleton Ihh protein is increased.

Downstream

Chondroma-like Lesion Formation

Show evidence (3 references)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Importantly, treatment with an inhibitor of IHH signaling reduced the occurrence of chondroma-like lesions in Fgfr3-deficient mice."

A rescue experiment, which is stronger than the correlation - blocking the pathway reduces the phenotype it is proposed to cause.

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"we revealed that deficiency of fgfr3 leads to enhanced IHH signaling and up-regulated canonical Wnt/β-catenin signaling, and pharmacological inhibition of Wnt/β-catenin could partially alleviate the phenotypes of fgfr3 mutants."

A second species reaching the same hedgehog result, and adding canonical Wnt as a parallel derepressed pathway.

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Ihh and Pthrp mRNA levels were increased in Fgfr3-deficient chondrocytes"

Primary-cell evidence of the Hedgehog/PTHrP response.

Enhanced Canonical Wnt Signaling

Mechanism confidence: Provisional

Mutant zebrafish cranial skeleton shows increased active beta-catenin and axin2 expression. Wnt inhibition partly improves cartilage architecture. The molecular connection from FGFR3 loss to Wnt activation, and whether IHH mediates it, remain unresolved; a direct serial IHH-to-Wnt mechanism is not established.

canonical Wnt signaling pathway GO:0060070 ↑ INCREASED

Animal models

fgfr3 knockout zebrafish Zebrafish partially recapitulates Active beta-catenin and axin2 are increased.

Downstream

Disordered Growth Plate Architecture Partial pharmacological rescue supports a contribution to cartilage disorganization in fish.

Show evidence (1 reference)

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the level of non-phosphorylated β-catenin (activated-β-catenin) was remarkably up-regulated in fgfr3 mutants"

Direct signaling measurement in zebrafish head skeleton.

Increased Growth Plate Chondrocyte Proliferation

Mechanism confidence: Provisional

Fgfr3 deletion increases growth-plate chondrocyte proliferation in mouse and zebrafish models, contributing to increased cartilage output. This is distinct from cell hypertrophy and from the reduced proliferation of cranial osteoblasts in mutant fish.

growth plate cartilage chondrocyte CL:1000217

growth plate cartilage chondrocyte proliferation GO:0003419 ↑ INCREASED

Downstream

Endochondral Bone and Vertebral Overgrowth Greater chondrocyte output contributes to longitudinal growth.

Show evidence (1 reference)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"showed an irregular distribution in the proliferative and hypertrophic zones in mutants and had higher rates of proliferation"

PCNA/Ki67 findings in mutant mouse growth plates.

Increased Chondrocyte Hypertrophy

Mechanism confidence: Provisional

Growth plates expand their hypertrophic compartment after Fgfr3 loss. In conditional mice, hypertrophic and terminal differentiation markers increase; fish cartilage contains abnormally enlarged cells. This model-supported mechanism contributes to cartilage overgrowth and architectural disruption.

hypertrophic chondrocyte CL:0000743

chondrocyte hypertrophy GO:0003415 ↑ INCREASED

Downstream

Endochondral Bone and Vertebral Overgrowth Expanded hypertrophic output contributes to endochondral elongation.

Disordered Growth Plate Architecture Hypertrophy and architectural disorganization coexist in the mutant growth plate; the experiment does not establish a direct causal step between them.

Show evidence (2 references)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Immunoreactivity for these markers was increased in Fgfr3 cKO relative to control mice"

Increased collagen X and MMP13 staining supports altered hypertrophic differentiation.

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the proportion of chondrocytes with abnormally enlarged volume and hypertrophy was increased significantly in fgfr3 mutants"

Fish chondrocyte enlargement measured histologically.

Disordered Growth Plate Architecture

Mechanism confidence: Provisional

Conditional Fgfr3 loss disrupts columnar organization and chondrocyte polarity, including primary-cilium orientation, in mouse growth plates. Mutant fish also show disordered chondrocyte arrangement and cartilage collagen organization. These structural abnormalities can contribute to cartilage dysplasia and chondroma-like lesions.

growth plate cartilage UBERON:0004129

Animal models

Chondrocyte-specific postnatal Fgfr3 knockout mouse Mouse partially recapitulates Expanded growth plates lose orderly chondrocyte columns.

fgfr3 knockout zebrafish Zebrafish rescues XAV939 partly improves cartilage arrangement and hypertrophy.

Downstream

Chondroma-like Lesion Formation Disorganized growth plates accompany the formation of ectopic cartilage masses.

Show evidence (2 references)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"growth plates in mutants were expanded and the columnar morphology of chondrocytes was lost"

Direct histology of disordered mouse growth plates.

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the collagen fibers lost its symmetry with disrupted organization in fgfr3 mutant chondrocytes"

Cartilage-matrix organization in fish.

Reduced Hypertrophic Chondrocyte Apoptosis

Mechanism confidence: Provisional

Hypertrophic-zone apoptosis is reduced in conditional mutant mice, which may contribute to cell accumulation and cartilage lesions. This effect depends on tissue context: isolated primary chondrocytes did not show the same basal apoptosis difference.

hypertrophic chondrocyte CL:0000743

Downstream

Chondroma-like Lesion Formation Reduced clearance may contribute to cell accumulation; this contribution was not isolated experimentally.

Show evidence (2 references)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the proportion of TUNEL-positive cells relative to the total number of hypertrophic chondrocytes was significantly reduced in mutants as compared to control mice"

In vivo apoptosis result.

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT In Vitro

"In primary chondrocytes isolated from Fgfr3 cKO mice, the proportion of TUNEL-positive cells was similar to control levels"

The isolated-cell result limits generalization of the in vivo apoptosis defect.

Endochondral Bone and Vertebral Overgrowth

Mechanism confidence: Established

Increased growth-plate output lengthens long bones and vertebral bodies. Human radiographs show tall vertebrae and broad femoral metaphyses with long shafts. Altered vertebral growth may contribute to spinal deformity, but the mechanical sequence has not been established in patients. The disease is not restricted categorically to endochondral bones: cranial findings and fish intramembranous-ossification defects require separate consideration.

endochondral bone growth GO:0003416 ↑ INCREASED

growth plate cartilage UBERON:0004129

Animal models

Fgfr3-null mouse Mouse partially recapitulates Skeletal overgrowth of long bones and vertebrae with kyphosis and scoliosis, matching the human radiographic pattern.

Deng Fgfr3-null skeletal model Mouse partially recapitulates Progressive skeletal dysplasia with prolonged endochondral bone growth.

Spider lamb syndrome sheep Sheep partially recapitulates Natural inherited receptor impairment is associated with skeletal elongation.

Downstream

Tall Stature Long-bone elongation contributes to increased stature.

Tall Vertebral Bodies Increased vertebral length is the corresponding radiographic feature.

Scoliosis Altered vertebral growth is proposed to predispose to spinal curvature; precise human biomechanics remain untested.

Tibial Bowing Fgfr3-null mice show curvature as well as overgrowth of long bones, the model counterpart of the bowed tibiae and fibulae of the homozygous Thr546Lys brothers. The human deformity has not been traced to a specific growth-plate process.

Wide Femoral Metaphysis Altered endochondral growth produces broad metaphyses in the human radiographic phenotype.

Arachnodactyly Elongated digital bones contribute to long slender digits.

Show evidence (3 references)

PMID:8601314 SUPPORT DIRECT PRIMARY RESULT Model Organism

"We have identified a role for fibroblast growth factor receptor 3 (FGFR-3) in this process by disrupting the murine Fgfr-3 gene to produce severe and progressive bone dysplasia with enhanced and prolonged endochondral bone growth."

Establishes enhanced and prolonged endochondral growth as the tissue-level result of losing the receptor.

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Radiographic findings included tall vertebral bodies with irregular borders and broad femoral metaphyses with long tubular shafts"

The human radiographic counterpart of the mouse overgrowth phenotype.

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"These findings indicate that abnormal FGFR3 signaling can cause human anomalies by promoting as well as inhibiting endochondral bone growth."

States the bidirectional axis that makes this entry the counterpart of the achondroplasia group.

Reduced Cranial Osteoblast Differentiation

Mechanism confidence: Provisional

Fgfr3-mutant zebrafish have reduced osteoblast differentiation-marker expression and fewer proliferating Osterix-positive cells in the head skeleton. This cranial model phenotype differs from increased growth-plate chondrocyte proliferation; its contribution to human cranial findings remains inferred.

osteoblast differentiation GO:0001649 ↓ DECREASED

Downstream

Delayed Cranial Ossification Reduced osteoblast maturation contributes to delayed cranial mineralization.

Show evidence (1 reference)

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the expressions of col1a2, osteopontin (spp1), osteonectin (osn), which were the later markers of osteoblast differentiation, were decreased in fgfr3 mutants"

Reduced osteoblast differentiation-marker expression in fish.

Delayed Cranial Ossification

Mechanism confidence: Provisional

Fgfr3-mutant zebrafish show delayed cranial mineralization, persistent sutures and separate small bone islands. These findings offer a model for sutural abnormalities such as human Wormian bones; they do not establish a cause of intellectual disability or all human microcephaly. Wnt inhibition did not significantly restore intramembranous ossification.

bone mineralization GO:0030282 ↓ DECREASED

Animal models

fgfr3 knockout zebrafish Zebrafish partially recapitulates Intramembranous cranial bones remain poorly mineralized.

Downstream

Wormian Bones Separate cranial bone islands in fish resemble the human sutural-bone phenotype.

Show evidence (2 references)

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Both the frontal suture and coronal suture were not closed even at adult stage in fgfr3 mutants."

Delayed suture closure in fish.

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the delayed intramembranous ossification of opercle and branchiostegal rays was not significantly changed in XAV939-treated mutants"

Negative treatment readout distinct from improved cartilage architecture.

Chondroma-like Lesion Formation

Mechanism confidence: Provisional

Disordered growth plates lacking FGFR3 generate enchondroma- and osteochondroma-like cartilage lesions in mice. Several members of the Utah pedigree had a solitary osteochondroma of the femur, tibia or a phalanx, which is the human observation this node is anchored to. The link between the two is not established: the human lesions are solitary and were not examined for hedgehog activity, while the mouse lesions are multiple and mechanistically dissected, so the node records a plausible correspondence rather than a demonstrated one.

Animal models

Chondrocyte-specific postnatal Fgfr3 knockout mouse Mouse partially recapitulates Multiple enchondroma- and osteochondroma-like lesions adjacent to disordered growth plates, with reduced ERK and raised IHH, and fewer lesions when hedgehog signaling is blocked.

Chondrocyte-specific postnatal Fgfr3 knockout mouse Mouse rescues Hedgehog inhibition prevented lesion formation during the treatment window.

Downstream

Osteochondroma Mouse cartilage lesions partly resemble the solitary human lesions; pathway identity has not been tested in patients.

Show evidence (2 references)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"we found that postnatal chondrocyte-specific Fgfr3 deletion induced multiple chondroma-like lesions, including enchondromas and osteochondromas, adjacent to disordered growth plates."

The model-system observation of cartilage lesions arising from Fgfr3 loss.

PMID:17033969 SUPPORT INDIRECT PRIMARY RESULT Human Clinical

"Several affected individuals had a single osteochondroma of the femur, the tibia, or a phalanx"

The human counterpart. Graded INDIRECT because the report records the lesions without linking them to FGFR3 signaling in those individuals.

Failure of Cochlear Pillar Cell Differentiation

Mechanism confidence: Provisional

Fgfr3-null mice fail to develop inner pillar cells, while outer pillar-cell differentiation stalls and the tunnel of Corti fails to form. This provides a model-based explanation for human sensorineural hearing loss, but normal clinical CT/MRI does not demonstrate a pillar-cell defect in patients. Human hearing severity ranges from mild to severe and is not invariably profound.

Cochlear pillar cell CL:1000191

inner ear morphogenesis GO:0042472 ⚠ ABNORMAL

organ of Corti UBERON:0002227

Animal models

Fgfr3-null mouse Mouse partially recapitulates Pillar cells fail to differentiate and the tunnel of Corti does not form, producing profound deafness - the cellular lesion the human sensorineural hearing loss is attributed to.

Downstream

Sensorineural Hearing Loss Pillar/tunnel disruption causes mouse deafness and is a proposed substrate of human hearing loss.

Show evidence (2 references)

PMID:8630492 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Inner ear defects include failure of pillar cell differentiation and tunnel of Corti formation and result in profound deafness."

The cellular lesion behind the hearing loss, demonstrated in the null mouse.

PMID:17117437 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the inner pillar cell never develops, while the outer pillar cell is stalled in its differentiation"

Distinguishes the two pillar-cell developmental abnormalities in null mice.

Altered Cochlear Sensory Epithelial Patterning

Mechanism confidence: Provisional

Fgfr3-null mice develop an additional row of outer hair cells and accompanying Deiters cells in the apical two thirds of the organ of Corti. FGFR3 therefore regulates sensory/supporting-cell patterning as well as pillar-cell differentiation. The relative contribution of each lesion to hearing loss has not been separated in human CATSHL.

spiral organ of cochlea UBERON:0002227

Animal models

Fgfr3-null mouse Mouse partially recapitulates Additional supporting/hair-cell patterning defects were described on reexamination of null cochleae.

Downstream

Sensorineural Hearing Loss Abnormal epithelial patterning accompanies deafness in Fgfr3-null mice; its independent contribution is unresolved.

Show evidence (1 reference)

PMID:17117437 SUPPORT DIRECT PRIMARY RESULT Model Organism

"we found an extra row of outer hair cells, and accompanying Deiters' cells, in the apical two thirds of the organ of Corti in the Fgfr3 mutant."

Direct mouse cochlear patterning result.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

29

Ear 2

Sensorineural Hearing Loss Bilateral sensorineural hearing impairment HP:0008619

Show evidence (3 references)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"On audiological exam, each tested individual had bilateral sensorineural hearing loss and absent otoacoustic emissions"

Establishes the sensorineural character and the absent otoacoustic emissions.

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"By report, the hearing loss was congenital or developed in early infancy, progressed variably in early childhood, and ranged from mild to severe."

Infantile onset and variable early progression in the founding pedigree; later families expand onset into childhood.

PMID:37990933 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We report the case of a 12-year-old girl and her father who both had marked postnatal tall stature, camptodactyly and clinodactyly, scoliosis and juvenile-onset hearing loss."

Childhood-onset hearing loss in the Arg621Cys family broadens onset beyond infancy.

Small Ears Microtia HP:0008551

Show evidence (1 reference)

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"small ears, bifid uvula and peg-shaped incisors."

Cannova et al., Clinical Genetics 2024. Small ears were described among mild dysmorphic findings in the Italian proband.

Eye 1

Deeply Set Eyes HP:0000490

Show evidence (1 reference)

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"deeply set eyes, slight prognathism, small ears, bifid uvula"

Cannova et al., Clinical Genetics 2024. Deeply set eyes were described in the Arg621Cys proband, without evidence of a syndrome-wide frequency.

Genitourinary 1

Multicystic Kidney Dysplasia HP:0000003

Show evidence (1 reference)

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Pregnancy was uneventful, except for dysplastic multicystic right kidney"

Cannova et al., Clinical Genetics 2024. Unilateral right multicystic dysplastic kidney was observed prenatally in the Arg621Cys proband and subsequently atrophied. A single observation supports a possible phenotype expansion, with uncertain specificity.

Head and Neck 6

High Palate HP:0000218

Show evidence (1 reference)

PMID:32641982 SUPPORT DIRECT BACKGROUND Human Clinical

"Other clinical features of CATSHL syndrome include microcephaly, wormian skull bones, a high palate, pectus excavatum"

The zebrafish paper's introduction enumerates the human clinical features drawn from the three case reports. Graded HUMAN_CLINICAL because the sentence describes patients, not the fish. No frequency band: the sentence is a feature list with no denominators.

Wormian Bones HP:0002645

Show evidence (1 reference)

PMID:32641982 SUPPORT DIRECT BACKGROUND Human Clinical

"microcephaly, wormian skull bones, a high palate"

Same feature list. Graded HUMAN_CLINICAL for the same reason; no denominator, so no frequency band.

Microcephaly HP:0000252

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"several of these had microcephaly (head circumference <2nd percentile)"

Documents microcephaly with its measurement threshold. No frequency band - "several" of the 12 delayed individuals gives no usable denominator.

Peg-Shaped Incisors Conical incisor HP:0011065

Show evidence (1 reference)

PMID:37990933 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Interestingly, peg-shaped incisors were observed in the proband, a feature never reported in CATSHL but typical of another FGFR3-related condition, LADD (Lacrimo - Auricolo - Dento - Digital) syndrome."

Records the finding and the authors' own caveat that it had never been reported in CATSHL before.

Bifid Uvula HP:0000193

Show evidence (1 reference)

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"small ears, bifid uvula and peg-shaped incisors."

Cannova et al., Clinical Genetics 2024. A bifid uvula was one of the mild dysmorphic findings in the Arg621Cys proband.

High Anterior Hairline HP:0009890

Show evidence (1 reference)

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Mild dysmorphic features include high frontal hairline"

Cannova et al., Clinical Genetics 2024. A high frontal hairline was described in the Arg621Cys proband.

Limbs 8

Camptodactyly of Toe HP:0001836

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Camptodactyly of the hands and/or feet"

Records foot involvement. No frequency is given because the published count pools hands and feet, so no toe-specific denominator exists.

Wide Femoral Metaphysis HP:0006417

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"broad femoral metaphyses with long tubular shafts"

Direct radiographic description of the metaphyseal phenotype.

Arachnodactyly HP:0001166

Show evidence (1 reference)

PMID:24864036 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The clinical picture is characterized by tall stature and severe skeletal abnormalities leading to inability to walk, with camptodactyly, arachnodactyly, and scoliosis."

Reports arachnodactyly in the biallelic family.

Clinodactyly HP:0030084

Show evidence (1 reference)

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She also had clinodactyly and proximal placement of the fifth toes bilaterally"

Cannova et al., Clinical Genetics 2024. Finger clinodactyly occurred in both Italian Arg621Cys family members; the proband also had bilateral fifth-toe clinodactyly.

Genu Valgum HP:0002857

Show evidence (1 reference)

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She also had val-gus knees and flat feet."

Cannova et al., Clinical Genetics 2024. Valgus knees were recorded in the Arg621Cys proband and in other ascertained families.

Pes Planus HP:0001763

Show evidence (1 reference)

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She also had val-gus knees and flat feet."

Cannova et al., Clinical Genetics 2024. Flat feet were documented in the Arg621Cys proband.

Coxa Valga HP:0002673

Show evidence (1 reference)

url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d SUPPORT DIRECT REVIEW SYNTHESIS Other

"right coxa valga of the right femoral neck"

Right coxa valga was recorded in the 2016 proband; this annotation uses the ClinGen expert abstraction because the primary full text was unavailable.

Tibial Bowing HP:0002982

Sequelae: Loss of Ambulation

Show evidence (2 references)

url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d SUPPORT DIRECT REVIEW SYNTHESIS Other

"deformed bowed tibiae and fibulae, arachnodactyly, wormian bones"

ClinGen summarizes the radiographic findings of Makrythanasis et al.

PMID:24864036 SUPPORT INDIRECT PRIMARY RESULT Human Clinical

"The clinical picture is characterized by tall stature and severe skeletal abnormalities leading to inability to walk"

Primary report of the severe skeletal deformity in the homozygous brothers. INDIRECT because the quoted abstract sentence does not name the tibia; the lateral tibial deviation appears in the paper's title and in ClinGen's abstraction of the full report.

Musculoskeletal 7

Camptodactyly HP:0012385

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"was present in 18 (90%) of 20 individuals, and 17 (85%) of 20 had hearing loss"

90% of genotyped individuals had camptodactyly, supporting VERY_FREQUENT.

Context-specific annotations (1)

Clinically studied members of the founding Utah pedigree VERY_FREQUENT

18/20 in the reported family subset; not a population penetrance estimate.

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"was present in 18 (90%) of 20 individuals, and 17 (85%) of 20 had hearing loss"

90% of genotyped individuals had camptodactyly, supporting VERY_FREQUENT.

Scoliosis HP:0002650

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"pectus abnormalities; and/or severe thoracolumbar kyphoscoliosis"

Records the severe end of the spinal phenotype.

Pectus Excavatum HP:0000767

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Several had scoliosis and/or a pectus excavatum"

The primary report of the finding in the founding pedigree.

Osteochondroma HP:0030431

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Several affected individuals had a single osteochondroma of the femur, the tibia, or a phalanx"

Records the lesion and its sites; no denominator is given, so no frequency band.

Tall Vertebral Bodies Increased vertebral height HP:0004570

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Radiographic findings included tall vertebral bodies with irregular borders"

Direct radiographic description of the vertebral phenotype.

Joint Hypermobility HP:0001382

Show evidence (1 reference)

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"She showed mild joint hyperextensibility with Beighton score of 5/9"

Cannova et al., Clinical Genetics 2024. Mild joint hyperextensibility with a Beighton score of 5/9 was described in the Arg621Cys proband.

Accelerated Skeletal Maturation HP:0005616

Show evidence (1 reference)

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"carpal x-ray revealed a bone age 4 years older than chronological age."

Cannova et al., Clinical Genetics 2024. Carpal bone age was four years ahead of chronological age in the Italian proband; this is a single-case observation.

Nervous System 3

Intellectual Disability HP:0001249

Show evidence (2 references)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Of 20 individuals, 12 (60%) had developmental delay and/or mental retardation, and several of these had microcephaly (head circumference <2nd percentile)."

The combined 12/20 developmental-delay and/or intellectual-disability count establishes occurrence but cannot yield a separate frequency for this phenotype.

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Her intellectual and social development was nor-mal."

Cannova et al., Clinical Genetics 2024: normal development in the 12-year-old proband demonstrates variability.

Neurodevelopmental Delay HP:0012758

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Of 20 individuals, 12 (60%) had developmental delay and/or mental retardation, and several of these had microcephaly (head circumference <2nd percentile)."

The combined 12/20 developmental-delay and/or intellectual-disability count establishes occurrence but cannot yield a separate frequency for this phenotype.

Loss of Ambulation Inability to walk HP:0002540

Show evidence (1 reference)

PMID:24864036 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"severe skeletal abnormalities leading to inability to walk"

Records loss of ambulation in the homozygous brothers.

Growth 1

Tall Stature HP:0000098

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Adult height in males was >97th percentile in 5 of 5 men, with a mean height of 77 inches, and adult height in females was >75th percentile in 9 of 9 and >97th percentile in 8 of 9 women, with a mean height of 70 inches."

Gives per-sex counts above the 97th and 75th centiles, supporting a VERY_FREQUENT band.

Context-specific annotations (1)

Clinically studied members of the founding Utah pedigree VERY_FREQUENT

13/14 in the reported family subset; not a population penetrance estimate.

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Adult height in males was >97th percentile in 5 of 5 men, with a mean height of 77 inches, and adult height in females was >75th percentile in 9 of 9 and >97th percentile in 8 of 9 women, with a mean height of 70 inches."

Gives per-sex counts above the 97th and 75th centiles, supporting a VERY_FREQUENT band.

🧬

Genetic Associations

1

FGFR3

Gene: FGFR3 hgnc:3690 gene page relationship_type: UNKNOWN

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"We mapped the locus causing a novel disorder characterized by camptodactyly, tall stature, scoliosis, and hearing loss (CATSHL syndrome) to chromosome 4p."

Establishes the 4p locus that contains FGFR3 and led to the gene assignment.

Variants (6)

c.1862G>A (p.Arg621His)

Heterozygous c.1862G>A (p.Arg621His), the founding Utah allele, was identified in all 20 tested affected relatives and subsequently reported in an independent family. The original paper contains a reversed amino-acid wording in one sentence; the consistent HGVS identity is Arg621His.

Show evidence (2 references)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"we screened FGFR3 and subsequently identified a heterozygous missense mutation that is predicted to cause a p.R621H substitution in the tyrosine kinase domain and partial loss of FGFR3 function."

Names the allele and its predicted functional consequence.

url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d SUPPORT DIRECT REVIEW SYNTHESIS Other

"(p.Arg621His) ... ClinGen Allele Registry: ... CA126386 ... Monoallelic heterozygous"

ClinGen records the recurrent allele in both Toydemir and Escobar probands.

c.1861C>T (p.Arg621Cys)

Heterozygous c.1861C>T (p.Arg621Cys), reported using NM_000142.5 in an Italian father and daughter; classified likely pathogenic by the report. Clinical overlap with LADD remains a phenotype-boundary question.

Show evidence (1 reference)

PMID:37990933 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"molecular analysis revealed a hitherto unreported, monoallelic variant c.1861C>T (p.Arg621Cys) in FGFR3."

Names the second dominant allele at Arg621.

c.1637C>A (p.Thr546Lys)

Homozygous NM_000142.4:c.1637C>A (p.Thr546Lys) in two Egyptian brothers with severe lower-limb deformity. Subtle parental skeletal features are described in ClinGen; the report does not provide a controlled dosage comparison with the Arg621 alleles.

Show evidence (1 reference)

PMID:24864036 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Whole exome sequencing revealed a homozygous novel missense mutation in the FGFR3 gene in exon 12 (NM_000142.4:c.1637C>A: p.(Thr546Lys))."

Names the biallelic allele with its transcript-level description.

c.1618A>G (p.Asn540Asp)

Homozygous candidate spectrum variant in Brazilian proband RC-26 with prelingual mild-to-moderate hearing loss, camptodactyly and microcephaly but average stature. The authors considered it likely pathogenic/causative, while their table records VUS or LP/VUS database assessments. No functional assay was reported; this observation does not establish classic CATSHL or a universal loss-of-function effect for substitutions at residue 540.

Show evidence (2 references)

PMID:39498320 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Proband RC-26 had a likely pathogenic variant in homozygosis in FGFR3"

Authors report a candidate homozygous FGFR3 finding; pathogenicity and the syndrome boundary remain uncertain.

PMID:39498320 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Height was average and flexion restriction of the third digit was observed in both hands."

The case lacks the characteristic tall stature of classic CATSHL.

c.1541C>A (p.Ala514Asp)

A heterozygous finding in the 2024 familial-tall-stature study, included with low case-level weight in the 2026 ClinGen reevaluation. These broader growth-phenotype cases do not establish the complete CATSHL triad or an experimentally measured receptor loss-of-function effect.

Show evidence (2 references)

url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d SUPPORT DIRECT REVIEW SYNTHESIS Other

"(p.Ala514Asp) ... ClinGen Allele Registry: ... CA355981408 ... Monoallelic heterozygous"

Expert abstraction of Gregorova et al. (PMID:38307035); retain as a qualified reported finding, not definitive allele causality.

PMID:38307035 SUPPORT INDIRECT PRIMARY RESULT Human Clinical

"The genetic cause of FTS was elucidated in 11/34 (32.4%) children ... FGFR3, CHD8, GPC3, and PPP2R5D genes"

Primary study behind the ClinGen abstraction of p.Ala514Asp. The abstract counts an FGFR3 variant among the causative findings in familial tall stature but names neither allele and does not report the CATSHL triad; the allele identities come from ClinGen's abstraction of the full text.

c.1959C>A (p.Asn653Lys)

A heterozygous finding in the 2024 familial-tall-stature study, included with low case-level weight in the 2026 ClinGen reevaluation. These broader growth-phenotype cases do not establish the complete CATSHL triad or an experimentally measured receptor loss-of-function effect.

Show evidence (2 references)

url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d SUPPORT DIRECT REVIEW SYNTHESIS Other

"(p.Asn653Lys) ... ClinGen Allele Registry: ... CA355982647 ... Monoallelic heterozygous"

Expert abstraction of Gregorova et al. (PMID:38307035); retain as a qualified reported finding, not definitive allele causality.

PMID:38307035 SUPPORT INDIRECT PRIMARY RESULT Human Clinical

"The genetic cause of FTS was elucidated in 11/34 (32.4%) children ... FGFR3, CHD8, GPC3, and PPP2R5D genes"

Primary study behind the ClinGen abstraction of p.Asn653Lys. The abstract counts an FGFR3 variant among the causative findings in familial tall stature but names neither allele and does not report the CATSHL triad; the allele identities come from ClinGen's abstraction of the full text.

💊

Medical Actions

6

Hearing Amplification

Action: Hearing rehabilitation with amplification Ontology label: Rehabilitation NCIT:C15315

Platform: Device

Audiological evaluation and hearing amplification are supportive management options for sensorineural loss. FGFR3 clinical-care resources recommend early recognition and treatment of hearing impairment, but the cited sources do not provide CATSHL-specific hearing-aid outcome estimates.

Target Phenotypes: Bilateral sensorineural hearing impairment HP:0008619

Show evidence (2 references)

url:https://research.nhgri.nih.gov/CGD/view/?g=FGFR3 SUPPORT DIRECT REVIEW SYNTHESIS Other

"Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development"

NHGRI clinical-care summary for the FGFR3 group including CATSHL; management rationale, not a CATSHL treatment trial.

PMID:35793999 SUPPORT DIRECT REVIEW SYNTHESIS Other

"Other treatment interventions may include antiseizure medications, hearing aids, and individualized developmental support."

General FGFR3 skeletal-dysplasia supportive care; only hearing aids are used to support this intervention.

Scoliosis Surgery

Action: orthopedic surgical procedure Ontology label: Orthopedic Surgical Procedure NCIT:C16186

Platform: Surgery

Spinal surgery was performed at age 23 for scoliosis in the Italian Arg621Cys father. The case establishes use, not comparative effectiveness or a standardized CATSHL surgical protocol.

Target Phenotypes: Scoliosis HP:0002650

Show evidence (1 reference)

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"He had thoracic scoliosis that required spinal surgery at the age of 23."

Cannova et al. document surgery in the affected father.

Genetic Counseling

Action: genetic counseling Ontology label: Genetic Counseling NCIT:C15240

Counseling depends on the allele, parental genotype and uncertain penetrance. A heterozygous dominant-associated allele has a 50% transmission probability per pregnancy; if both parents carry the same recessive-associated allele, each pregnancy has a 25% probability of homozygosity. These are conditional genotype probabilities, not guarantees of phenotype or severity. Subtle heterozygous manifestations and the Moderate gene-disease validity assessment should inform interpretation.

Show evidence (1 reference)

url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d SUPPORT DIRECT REVIEW SYNTHESIS Other

"Mother and father are mildly affected with slight tall stature, relative microcephaly, and long lower limbs."

ClinGen family abstraction supports counseling that heterozygous phenotype need not be completely absent. The Mendelian genotype probabilities are conditional inferences.

Developmental Support

Action: Rehabilitation NCIT:C15315

Platform: Behavioral / lifestyle

Individualized developmental support is a general supportive-care option when delay or learning difficulties are present; no CATSHL-specific efficacy study is reported in the cited review.

Target Phenotypes: Neurodevelopmental delay HP:0012758 Intellectual disability HP:0001249

Show evidence (1 reference)

PMID:35793999 SUPPORT DIRECT REVIEW SYNTHESIS Other

"Other treatment interventions may include antiseizure medications, hearing aids, and individualized developmental support."

General FGFR3-disorder review supports individualized developmental care, not a disease-specific effect estimate.

Experimental Hedgehog Inhibition

Action: Pharmacotherapy NCIT:C15986

Agent: Vismodegib NCIT:C74038

Platform: Small molecule

Vismodegib prevented chondroma-like lesions in conditional Fgfr3-deficient mice during a four-week treatment window. The same intervention induced premature growth-plate fusion and reduced long-bone length in controls and mutants. This is a preclinical pathway experiment with important developmental toxicity, not demonstrated CATSHL treatment.

Mechanism Target:

INHIBITS Derepressed Indian Hedgehog Signaling — Smoothened inhibition reduces Hedgehog signaling in the mouse experiment.

Show evidence (2 references)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"there were no chondroma-like lesions in the mutants after 4 weeks of SMOi treatment"

Mouse lesion prevention with GDC-0449/vismodegib.

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"adverse secondary effects were induced, including premature growth plate fusion leading to a shorter long bone"

Developmental toxicity limits therapeutic interpretation.

Experimental Wnt Inhibition

Action: Pharmacotherapy NCIT:C15986

Agent: XAV939 CHEBI:62878

Platform: Small molecule

XAV939 exposure at 2.5 micromolar from 10–20 days post fertilization partly improved cranial/cartilage abnormalities in fgfr3-mutant zebrafish. Delayed intramembranous ossification was not significantly corrected. This is a preclinical partial rescue and does not establish human efficacy or safety.

Mechanism Target:

INHIBITS Enhanced Canonical Wnt Signaling — XAV939 promotes beta-catenin degradation through axin stabilization in the fish experiment.

Show evidence (2 references)

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"The abnormal arrangement and hypertrophy of chondrocytes in ceratohyal cartilage were both alleviated in XAV939-treated mutants."

Partial cartilage rescue.

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the delayed intramembranous ossification of opercle and branchiostegal rays was not significantly changed in XAV939-treated mutants"

No significant rescue of the distinct intramembranous-ossification readout.

🔬

Diagnosis

2

FGFR3 sequencing

Phenotype-directed FGFR3 sequencing or broader sequencing can identify relevant kinase-domain variants, followed by segregation and variant interpretation. The founding family used linkage plus direct sequencing, the Thr546Lys brothers exome sequencing, and the Arg621Cys family targeted exon sequencing. A candidate case in a hearing-loss cohort was missed by a panel that omitted FGFR3 and detected by exome sequencing; a molecular finding alone does not establish pathogenicity.

Show evidence (2 references)

PMID:24864036 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Whole exome sequencing revealed a homozygous novel missense mutation in the FGFR3 gene in exon 12"

Documents molecular confirmation as the diagnostic route.

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT PRIMARY RESULT Human Clinical

"exon 14 and flanking exons of FGFR3 gene sequencing was performed."

Cannova et al. document targeted sequencing rather than a linkage study in the Italian family.

Audiometry with otoacoustic emissions

Audiometry and otoacoustic emissions characterize the hearing phenotype. The Utah family had bilateral sensorineural loss and absent emissions in tested individuals. Follow-up is relevant because childhood onset and variable progression occur; normal CT/MRI does not exclude a cochlear cellular lesion.

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"On audiological exam, each tested individual had bilateral sensorineural hearing loss and absent otoacoustic emissions"

Describes the audiological findings that define the test result.

📊

Prevalence

1

Founding Utah pedigree reported in 2006

Cases In Literature

The pedigree contained 35 historically affected individuals over seven generations, of whom 27 were living and 20 had clinical information and DNA available. This is a family count, not a population prevalence estimate. Later independent families and candidate spectrum cases preclude using this count as the worldwide total.

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"from a total of 35 affected individuals in seven generations"

Historical affected count in the founding pedigree; 27 were living and 20 studied.

🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from CATSHL Syndrome:

Marfan syndrome MONDO:0007947

Overlapping Features The obvious alternative for tall stature with arachnodactyly and scoliosis, and the one the original investigators formally excluded.

Distinguishing Features

The examined Utah relatives lacked severe myopia, lens dislocation and aortic-root abnormalities, which argued against Marfan syndrome in that pedigree.
The combination of digital contractures and sensorineural hearing loss supports consideration of CATSHL; cardiac or ocular findings in an individual still require independent assessment.

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"Marfan syndrome was considered a possible diagnosis, but no affected individuals who were examined had severe myopia, lens dislocation, or aortic-root abnormalities."

Records the exclusion and the features used to make it.

Hunter-MacDonald syndrome

Overlapping Features Shares camptodactyly, scoliosis and reduced hearing acuity, so it overlaps CATSHL on three of its four named features. Stature is the discriminator and it runs the opposite way.

Distinguishing Features

Short stature rather than tall stature.
Epiphyseal dysplasia with early osteoarthritis, and a predisposition to meningioma.

Show evidence (1 reference)

PMID:17972300 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The skeletal manifestations of HMS include short stature, scoliosis, epiphyseal dysplasia with early osteoarthritis leading to joint replacement, prominent humeral insertions for the deltoids, camptodactyly, subluxation of the thumbs, and malformed feet."

Lists the overlapping features together with the short stature that separates it from CATSHL.

LADD syndrome

Overlapping Features Another FGFR3-related condition. Relevant because peg-shaped incisors, a LADD feature, turned up in one CATSHL proband, so the dental finding does not separate the two as cleanly as it appears to.

Distinguishing Features

Lacrimal and salivary duct aplasia, hypoplasia or atresia are characteristic of LADD. Hearing, digital, dental and renal findings can overlap.
Tall stature and scoliosis favor the reported CATSHL pattern, but peg-shaped incisors and renal dysplasia in the Arg621Cys proband blur the clinical boundary.

Show evidence (2 references)

PMID:37990933 SUPPORT DIRECT PRIMARY RESULT Human Clinical

"The FGFR3 p.Arg621Cys variant seems to be a newly identified cause of CATSHL syndrome with some phenotypic overlap with the LADD syndrome."

States the overlap the authors themselves drew between the two FGFR3 conditions.

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical

"is characterized by aplasia, hypoplasia or atresia of the lacrimal and salivary ducts"

Cannova et al. review the differentiating duct abnormalities and shared findings.

🧫

Experimental Models

2

Fgfr3-deficient primary mouse chondrocytes PRIMARY_CELL_CULTURE

Primary chondrocytes test FGF18-induced ERK activity, Ihh/Pthrp expression and pathway inhibition. Basal apoptosis in isolated mutant cells did not reproduce the decrease observed in the hypertrophic zone in vivo.

Cell source

Knee-joint cartilage from three-day-old mice; deletion induced with 4-hydroxytamoxifen in culture

Publication

PMID:26091072

Pathograph links

Reduced MAPK/ERK Output in Growth Plate Chondrocytes partially recapitulates fidelity: moderate observes: molecular FGF18-induced ERK activation is reduced.

Limitations: Neonatal cultured cells are not patient growth-plate tissue.

Show evidence (1 reference)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT In Vitro

"MAPK activation in response to FGF18 was also reduced in Fgfr3-deficient chondrocytes"

Primary-cell signaling assay.

Derepressed Indian Hedgehog Signaling partially recapitulates fidelity: moderate observes: molecular Ihh/Pthrp expression rises after receptor deletion or MEK inhibition.

Limitations: Does not establish all downstream steps in patients.

Show evidence (1 reference)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT In Vitro

"Ihh and Pthrp mRNA levels were increased in Fgfr3-deficient chondrocytes"

Primary-cell gene-expression result.

Arg621His patient fibroblast expression observations PRIMARY_CELL_CULTURE

Patient fibroblasts expressed both mutant and wild-type transcripts, and receptor localization was described as normal. These observations inform proposed mechanisms but do not measure receptor kinase inhibition or functional rescue.

Cell source

Fibroblasts from affected members of the founding pedigree

Publication

PMID:17033969

No kinase-activity or rescue link is assigned to these expression/localization observations.

Show evidence (1 reference)

PMID:17033969 SUPPORT DIRECT PRIMARY RESULT In Vitro

"express both wild-type and mutant (i.e., p.R621H-containing)FGFR3RNA in nearly equal proportions"

Patient-cell expression result; the report states that related localization data were not shown.

🐁

Animal Models

5

Fgfr3-null mouse

Constitutive Fgfr3-null mice show skeletal overgrowth and profound deafness. The skeletal and cochlear findings suggested FGFR3 as a candidate in the original human pedigree; the null genotype is not the heterozygous human missense genotype.

Species

Mouse

Genotype

Fgfr3 homozygous targeted disruption

Publication

PMID:8630492

Pathograph links

Endochondral Bone and Vertebral Overgrowth partially recapitulates fidelity: moderate Skeletal overgrowth of long bones and vertebrae with kyphosis and scoliosis, matching the human radiographic pattern.

Limitations: The mouse is a complete null while the common human genotype is a heterozygous missense allele on a wild-type background, so the mouse represents a more severe loss of receptor function than the dominant human disease.

Readouts

Long bone and vertebral length

Direction: INCREASED

Interpretation: Structural correlate of the overgrowth node.

Show evidence (1 reference)

PMID:8630492 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Skeletal defects include kyphosis, scoliosis, crooked tails and curvature and overgrowth of long bones and vertebrae."

Reports the skeletal measurements behind this readout.

Show evidence (1 reference)

PMID:8630492 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Our results demonstrate that Fgfr3 is essential for normal endochondral ossification and inner ear development."

Supports treating the null mouse as informative for the endochondral overgrowth node.

Failure of Cochlear Pillar Cell Differentiation partially recapitulates fidelity: moderate Pillar cells fail to differentiate and the tunnel of Corti does not form, producing profound deafness - the cellular lesion the human sensorineural hearing loss is attributed to.

Limitations: The mouse deafness is static while the human hearing loss is progressive. The original authors read that difference as evidence that residual wild-type FGFR3 in heterozygotes delays rather than prevents the defect, and as a hint that pillar cells need FGFR3 for maintenance as well as formation - neither of which the null mouse can test.

Readouts

Pillar cell differentiation and tunnel of Corti formation

Direction: ABOLISHED

Interpretation: Histological correlate of the cochlear node.

Show evidence (1 reference)

PMID:8630492 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Inner ear defects include failure of pillar cell differentiation and tunnel of Corti formation and result in profound deafness."

Reports the cochlear histology and the resulting deafness.

Show evidence (1 reference)

PMID:8630492 SUPPORT DIRECT BACKGROUND Model Organism

"Fibroblast growth factor receptor 3 (Fgfr3) is a tyrosine kinase receptor expressed in developing bone, cochlea, brain and spinal cord."

Establishes cochlear expression, which is why the null mouse is informative for this node.

Altered Cochlear Sensory Epithelial Patterning partially recapitulates fidelity: moderate observes: tissue Additional supporting/hair-cell patterning defects were described on reexamination of null cochleae.

Limitations: Anatomical patterning is a model readout; human cochlear tissue was not examined.

Show evidence (1 reference)

PMID:17117437 SUPPORT DIRECT PRIMARY RESULT Model Organism

"we found an extra row of outer hair cells, and accompanying Deiters' cells, in the apical two thirds of the organ of Corti in the Fgfr3 mutant."

Mouse cochlear phenotype, not human histology.

Deng Fgfr3-null skeletal model

Independent constitutive knockout study establishing FGFR3 as a negative regulator of bone growth; its cited abstract focuses on skeletal rather than auditory findings.

Species

Mouse

Genotype

Homozygous targeted Fgfr3 disruption

Publication

PMID:8601314

Pathograph links

Endochondral Bone and Vertebral Overgrowth partially recapitulates fidelity: moderate observes: tissue Progressive skeletal dysplasia with prolonged endochondral bone growth.

Limitations: Complete receptor deletion does not establish the biochemical action of individual human missense alleles.

Show evidence (1 reference)

PMID:8601314 SUPPORT DIRECT PRIMARY RESULT Model Organism

"severe and progressive bone dysplasia with enhanced and prolonged endochondral bone growth"

Direct knockout skeletal phenotype.

Chondrocyte-specific postnatal Fgfr3 knockout mouse

Deletion induced after four weeks of age yields disorganized growth plates and multiple osteochondroma-/enchondroma-like lesions. Mosaic lesions contain mutant and unrecombined cells. Vismodegib suppresses lesion formation but also causes premature growth-plate fusion and shortened long bones.

Species

Mouse

Genotype

Fgfr3 floxed alleles with tamoxifen-inducible Col2a1-CreERT2

Publication

PMID:26091072

Pathograph links

Chondroma-like Lesion Formation partially recapitulates fidelity: moderate Multiple enchondroma- and osteochondroma-like lesions adjacent to disordered growth plates, with reduced ERK and raised IHH, and fewer lesions when hedgehog signaling is blocked.

Limitations: The mouse lesions are multiple and the human lesions solitary, and no CATSHL patient lesion has been examined for ERK or hedgehog activity, so the shared mechanism is inferred from the shared genotype rather than measured in humans.

Readouts

Chondroma-like lesion count

Direction: INCREASED

Interpretation: The lesion burden that hedgehog inhibition reduces.

Show evidence (1 reference)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Importantly, treatment with an inhibitor of IHH signaling reduced the occurrence of chondroma-like lesions in Fgfr3-deficient mice."

Reports the lesion count responding to pathway inhibition.

Show evidence (1 reference)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"This is the first study reporting that the loss of Fgfr3 function leads to the formation of chondroma-like lesions via downregulation of MEK/ERK signaling and upregulation of IHH, suggesting that FGFR3 has a tumor suppressor-like function in chondrogenesis."

Supports treating this model as informative for the lesion node and names the proposed mechanism.

Derepressed Indian Hedgehog Signaling partially recapitulates fidelity: moderate The model is where the raised IHH and lowered ERK were actually measured.

Limitations: Measured in mouse cartilage only; the equivalent measurement has never been made in human CATSHL tissue.

Readouts

Indian hedgehog expression in growth plate cartilage

Direction: INCREASED

Interpretation: The molecular readout defining this node.

Show evidence (1 reference)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"The lesions showed decreased extracellular signal-regulated kinase (ERK) activity and increased Indian hedgehog (IHH) expression."

The direct measurement of both pathway changes.

Disordered Growth Plate Architecture partially recapitulates fidelity: moderate observes: tissue Expanded growth plates lose orderly chondrocyte columns.

Limitations: Multiple mouse lesions exceed the solitary osteochondromas described in the founding human family.

Show evidence (1 reference)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"growth plates in mutants were expanded and the columnar morphology of chondrocytes was lost"

Conditional mouse growth-plate histology.

Chondroma-like Lesion Formation rescues fidelity: moderate observes: tissue Hedgehog inhibition prevented lesion formation during the treatment window.

Limitations: Prevention was accompanied by premature growth-plate fusion and reduced limb length; it is not established treatment of existing human lesions.

Show evidence (1 reference)

PMID:26091072 SUPPORT DIRECT PRIMARY RESULT Model Organism

"there were no chondroma-like lesions in the mutants after 4 weeks of SMOi treatment"

Vismodegib intervention in conditional mice.

fgfr3 knockout zebrafish

CRISPR/Cas9 AB-background mutants show craniofacial cartilage dysplasia, delayed ossification and cranial bone islands. Ceratohyal cartilage is elongated, but surviving adults have smaller overall body size, with severe jaw deformity affecting feeding. Weberian apparatus and swim bladder abnormalities suggest altered hearing; auditory function itself was not measured.

Species

Zebrafish

Genotype

Homozygous exon-11 frameshift deletion; 2-bp and 17-bp lines, predominantly the 17-bp line

Publication

PMID:32641982

Pathograph links

Derepressed Indian Hedgehog Signaling partially recapitulates fidelity: moderate observes: molecular Head-skeleton Ihh protein is increased.

Limitations: Does not prove that IHH lies upstream of Wnt in this model.

Show evidence (1 reference)

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Ihh protein was significantly increased in fgfr3 mutants"

Direct fish protein measurement.

Enhanced Canonical Wnt Signaling partially recapitulates fidelity: moderate observes: molecular Active beta-catenin and axin2 are increased.

Limitations: Upstream FGFR3-to-Wnt intermediates are unresolved.

Show evidence (1 reference)

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the expression level of axin2 was increased in head skeleton of fgfr3 mutants"

Wnt target-gene readout.

Disordered Growth Plate Architecture rescues fidelity: moderate observes: tissue XAV939 partly improves cartilage arrangement and hypertrophy.

Limitations: 2.5 micromolar XAV939 from 10–20 days post fertilization; cartilage rescue was incomplete and did not significantly improve intramembranous ossification.

Show evidence (1 reference)

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"The abnormal arrangement and hypertrophy of chondrocytes in ceratohyal cartilage were both alleviated in XAV939-treated mutants."

Pharmacological partial rescue in fish.

Delayed Cranial Ossification partially recapitulates fidelity: moderate observes: tissue Intramembranous cranial bones remain poorly mineralized.

Limitations: Fish cranial anatomy and body growth differ from human CATSHL; hearing loss was inferred from anatomy rather than measured.

Show evidence (1 reference)

PMID:32641982 SUPPORT DIRECT PRIMARY RESULT Model Organism

"Both the frontal suture and coronal suture were not closed even at adult stage in fgfr3 mutants."

Fish cranial phenotype.

Spider lamb syndrome sheep

Naturally occurring ovine hereditary chondrodysplasia caused by FGFR3 p.Val700Glu provides an inherited skeletal-overgrowth model. Homozygotes have severe deformity and heterozygotes can have increased long-bone length; genetic background modifies expression. The model does not establish human variant-specific mechanisms or a CATSHL cochlear phenotype.

Species

Sheep

Genotype

Fgfr3 p.Val700Glu, naturally occurring

Publication

PMID:16441300

Pathograph links

Endochondral Bone and Vertebral Overgrowth partially recapitulates fidelity: moderate observes: tissue Natural inherited receptor impairment is associated with skeletal elongation.

Limitations: Ovine p.Val700Glu is distinct from the human alleles; no human hearing phenotype is inferred. Greater frame size did not imply higher body weight or longissimus muscle area at a given age.

Show evidence (2 references)

PMID:16441300 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the mutant FGFR3 allele has an additive effect on long-bone length"

Primary ovine genetic study, replacing secondary citation through the human report.

+ 1 more reference

Show evidence (2 references)

PMID:16441300 SUPPORT DIRECT PRIMARY RESULT Model Organism

"the mutant FGFR3 allele has an additive effect on long-bone length"

Primary ovine genetic study, replacing secondary citation through the human report.

PMID:17032787 SUPPORT DIRECT PRIMARY RESULT Model Organism

"At maturity, FGFR3(SLS/+) ewes exhibited a larger frame size and longer bones than normal FGFR3(+/+) ewes"

Direct heterozygous sheep growth comparison.

🧮

Computational Models

1

Arg621His kinase-domain homology model STRUCTURAL_PREDICTION

The FGFR1 kinase crystal structure was used to infer the catalytic-loop role of the homologous FGFR3 Arg621 residue and model a histidine side chain.

PMID:17033969

Pathograph links

FGFR3 Kinase-Domain Loss of Function perturbs fidelity: low observes: molecular Structural modeling predicts interference with phosphate transfer.

Limitations: Uses a homologous receptor structure and does not demonstrate mutant/wild-type dimer inhibition.

Show evidence (1 reference)

PMID:17033969 SUPPORT INDIRECT PRIMARY RESULT Computational

"The p.R621H substitution may therefore interfere with the ability of FGFR3 to transfer phosphate to its peptide substrate, resulting in loss of function"

Structural prediction, not an enzymatic assay.

{ }

Source YAML

click to show

name: CATSHL Syndrome
category: Mendelian
creation_date: "2026-08-29T19:15:00Z"
synonyms:
- camptodactyly-tall stature-scoliosis-hearing loss syndrome
- camptodactyly, tall stature, and hearing loss syndrome
- CATSHLS
description: >-
  CATSHL syndrome is a rare FGFR3-related skeletal overgrowth disorder characterized by camptodactyly, tall stature, scoliosis and sensorineural hearing loss. Heterozygous Arg621 substitutions and a homozygous Thr546Lys substitution have been reported in classic families. Developmental delay, intellectual disability, microcephaly, chest deformity and osteochondroma are variable; an Arg621Cys family expands the reported phenotype to dental and renal anomalies. Hearing loss can begin in infancy or childhood. Reduced FGFR3 signaling is the proposed disease mechanism, supported by loss-of-function animal models, but direct functional characterization of the human alleles remains limited. ClinGen retained a Moderate gene-disease validity classification in its August 2026 reevaluation.
disease_term:
  preferred_term: CATSHL syndrome
  term:
    id: MONDO:0012504
    label: camptodactyly-tall stature-scoliosis-hearing loss syndrome
parents:
- FGFR3-related skeletal dysplasia
classifications:
  isds_skeletal_category:
  - classification_value: fgfr3_chondrodysplasia
    notes: >-
      ISDS Nosology and Classification of Genetic Skeletal Disorders, group 1
      "FGFR3 chondrodysplasia group"; CATSHL is the loss-of-function member of
      the group, which the Nosology lists alongside the gain-of-function
      disorders.
inheritance:
- name: Autosomal dominant
  description: >-
    Heterozygous p.Arg621His segregated in the founding Utah pedigree and was subsequently reported in an independent family; p.Arg621Cys was identified in an Italian father and daughter. The full penetrance reported in small ascertained families and assumed for the original linkage analysis is not a population penetrance estimate.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we screened FGFR3 and subsequently identified a heterozygous missense mutation that is predicted to cause a p.R621H substitution in the tyrosine kinase domain and partial loss of FGFR3 function."
    explanation: A heterozygous allele segregating through a multigeneration pedigree establishes dominant transmission.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:27139183
    reference_title: 'A second family with CATSHL syndrome: Confirmatory report of another unique FGFR3 syndrome.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Our family confirms the consistent and unique phenotype of this condition, and the specificity of the mutation in FGFR3.
    explanation: Independent 2016 family confirming the dominant phenotype; the small pedigree does not quantify population penetrance.
- name: Autosomal recessive
  description: >-
    Homozygous p.Thr546Lys was reported in two brothers of first-cousin parents with severe skeletal deformity. ClinGen describes subtle tall stature, relative microcephaly and long lower limbs in their parents and curates the broader gene-disease relationship as semidominant. Thus, the recessive presentation does not establish complete absence of effects in heterozygotes, nor does comparison with Arg621 families isolate an allele-dose effect.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:24864036
    reference_title: "A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report the phenotype and underlying molecular abnormality in two brothers, born to first cousin parents."
    explanation: Affected sibs of consanguineous parents carrying the variant homozygously indicate recessive inheritance for this allele.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d
    reference_title: curation results for Gene-Disease Validity
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Mother and father are mildly affected with slight tall stature, relative microcephaly, and long lower limbs.
    explanation: ClinGen expert abstraction of the 2014 family qualifies the baseline claim that heterozygous parents were entirely unaffected.
prevalence:
- population: Founding Utah pedigree reported in 2006
  measure_type: CASES_IN_LITERATURE
  notes: The pedigree contained 35 historically affected individuals over seven generations, of whom 27 were living and 20 had clinical information and DNA available. This is a family count, not a population prevalence estimate. Later independent families and candidate spectrum cases preclude using this count as the worldwide total.
  evidence:
  - reference: PMID:17033969
    reference_title: A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: from a total of 35 affected individuals in seven generations
    explanation: Historical affected count in the founding pedigree; 27 were living and 20 studied.
pathophysiology:
- name: FGFR3 Coding Missense Variation
  description: Germline single-nucleotide substitutions alter the FGFR3 kinase-domain coding sequence. Classic pedigrees carry heterozygous Arg621His or Arg621Cys, or homozygous Thr546Lys. Additional missense variants in tall-stature or hearing-loss cohorts require individual interpretation.
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:37990933
    reference_title: CATSHL syndrome, a new family and phenotypic expansion.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: molecular analysis revealed a hitherto unreported, monoallelic variant c.1861C>T (p.Arg621Cys) in FGFR3.
    explanation: Direct identification of a coding substitution.
  - reference: PMID:24864036
    reference_title: A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: 'Whole exome sequencing revealed a homozygous novel missense mutation in the FGFR3 gene in exon 12 (NM_000142.4:c.1637C>A: p.(Thr546Lys)).'
    explanation: Distinct homozygous coding substitution in the severe skeletal family.
  role: trigger
  gene:
    preferred_term: FGFR3
    term:
      id: hgnc:3690
      label: FGFR3
  genetic_context:
    gene:
      preferred_term: FGFR3
      term:
        id: hgnc:3690
        label: FGFR3
    variant_type: single nucleotide variant
    genomic_contexts:
    - coding sequence
    allele_type: MISSENSE
    variant_origin: GERMLINE
    notes: Zygosity varies by allele and family. A coding substitution is not itself proof of receptor loss of function.
  downstream:
  - target: FGFR3 Kinase-Domain Loss of Function
    description: Allele-specific impairment is inferred; functional testing is required to distinguish partial loss from dominant-negative activity.
    causal_link_type: UNKNOWN
- name: FGFR3 Kinase-Domain Loss of Function
  biological_scale: MOLECULAR
  role: central_effector
  mechanism_confidence: PROVISIONAL
  description: >-
    Reduced FGFR3 receptor signaling is inferred from the kinase-domain substitutions, structural modeling, segregation and the overlap with null-animal phenotypes. The Arg621His substitution may impair phosphate transfer, and a dominant-negative interaction with the wild-type receptor is proposed. Neither kinase inhibition by the human alleles nor mutant/wild-type heterodimer suppression was directly measured in the founding report. The direction of effect is supported by model systems and expert curation, while allele-specific biochemical mechanisms remain unresolved.
  gene:
    preferred_term: FGFR3
    description: >-
      FGFR3 receptor implicated by human missense variants and experimental loss-of-function models.
    modifier: LOSS_OF_FUNCTION
    term:
      id: hgnc:3690
      label: FGFR3
  molecular_functions:
  - preferred_term: fibroblast growth factor receptor activity
    term:
      id: GO:0005007
      label: fibroblast growth factor receptor activity
    modifier: DECREASED
  evidence:
  - reference: PMID:17033969
    reference_title: A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    quote_role: PRIMARY_RESULT
    directness: INDIRECT
    snippet: The p.R621H substitution may therefore interfere with the ability of FGFR3 to transfer phosphate to its peptide substrate, resulting in loss of function
    explanation: Homology-based mechanistic prediction, not a measured human-mutant kinase assay.
  - reference: PMID:17033969
    reference_title: A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: INDIRECT
    snippet: These observations suggest that p.R621H might, instead, cause loss of FGFR3 function by a dominant negative mechanism.
    explanation: Author inference from expression/localization and comparisons with null genotypes; not direct evidence of inhibitory heterodimerization.
  downstream:
  - target: Reduced MAPK/ERK Output in Growth Plate Chondrocytes
    description: Receptor loss reduces growth-plate ERK activation in mouse experiments.
    causal_link_type: DIRECT
  - target: Increased Growth Plate Chondrocyte Proliferation
    description: Increased proliferation follows Fgfr3 loss; the complete downstream signaling route is unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Increased Chondrocyte Hypertrophy
    description: FGFR3 loss releases restraint on hypertrophic differentiation through multiple pathways.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Disordered Growth Plate Architecture
    description: Null cartilage has abnormal polarity and organization; intervening determinants remain incompletely mapped.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Reduced Hypertrophic Chondrocyte Apoptosis
    description: Conditional loss reduces hypertrophic-cell apoptosis in vivo, with no corresponding isolated-cell change.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Enhanced Canonical Wnt Signaling
    description: The fish signaling association is supported, but the intervening molecular route is unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Reduced Cranial Osteoblast Differentiation
    description: Reduced osteoblast maturation is demonstrated in the fish model; human relevance is provisional.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Failure of Cochlear Pillar Cell Differentiation
    description: FGFR3-dependent developmental signaling specifies pillar-cell fate.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Altered Cochlear Sensory Epithelial Patterning
    description: Loss of the receptor changes sensory epithelial cell-fate patterning in mice.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Reduced MAPK/ERK Output in Growth Plate Chondrocytes
  biological_scale: MOLECULAR
  role: central_effector
  mechanism_confidence: PROVISIONAL
  description: >-
    Fgfr3-deficient mouse growth plates show reduced ERK phosphorylation, and isolated mutant chondrocytes respond less strongly to FGF18. Reduced MAPK output can release restraint on hypertrophic differentiation and increase Ihh expression. Increased proliferation after Fgfr3 loss is not assigned exclusively to ERK suppression, because ERK-specific perturbations can have different proliferation effects.
  cell_types:
  - preferred_term: Growth plate chondrocyte
    term:
      id: CL:1000217
      label: growth plate cartilage chondrocyte
  biological_processes:
  - preferred_term: fibroblast growth factor receptor signaling pathway
    term:
      id: GO:0008543
      label: fibroblast growth factor receptor signaling pathway
    modifier: DECREASED
  - preferred_term: ERK1 and ERK2 cascade
    term:
      id: GO:0070371
      label: ERK1 and ERK2 cascade
    modifier: DECREASED
  evidence:
  - reference: PMID:26091072
    reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: MAPK activation in response to FGF18 was also reduced in Fgfr3-deficient chondrocytes
    explanation: Direct primary-cell signaling result.
  - reference: PMID:26091072
    reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: MAPK activity was reduced in hypertrophic zones of Fgfr3 cKO mice
    explanation: In vivo growth-plate ERK result; human CATSHL tissue was not assayed.
  downstream:
  - target: Derepressed Indian Hedgehog Signaling
    description: MEK inhibition increases Ihh expression in primary chondrocytes.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Increased Chondrocyte Hypertrophy
    description: Reduced ERK signaling can release restraint on terminal chondrocyte differentiation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Derepressed Indian Hedgehog Signaling
  biological_scale: MOLECULAR
  role: central_effector
  mechanism_confidence: PROVISIONAL
  description: >-
    IHH expression increases in Fgfr3-deficient mouse growth plates and zebrafish cranial skeleton. Mouse primary-cell experiments show that MEK inhibition can increase Ihh and Pthrp expression. Hedgehog inhibition prevents cartilage lesions in the conditional mouse model, supporting a causal contribution in that model; its contribution in patients is unmeasured.
  biological_processes:
  - preferred_term: smoothened signaling pathway
    term:
      id: GO:0007224
      label: smoothened signaling pathway
    modifier: INCREASED
  evidence:
  - reference: PMID:26091072
    reference_title: "FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: "Importantly, treatment with an inhibitor of IHH signaling reduced the occurrence of chondroma-like lesions in Fgfr3-deficient mice."
    explanation: >-
      A rescue experiment, which is stronger than the correlation - blocking the
      pathway reduces the phenotype it is proposed to cause.
    quote_role: PRIMARY_RESULT
  - reference: PMID:32641982
    reference_title: "Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: "we revealed that deficiency of fgfr3 leads to enhanced IHH signaling and up-regulated canonical Wnt/β-catenin signaling, and pharmacological inhibition of Wnt/β-catenin could partially alleviate the phenotypes of fgfr3 mutants."
    explanation: >-
      A second species reaching the same hedgehog result, and adding canonical
      Wnt as a parallel derepressed pathway.
    quote_role: PRIMARY_RESULT
  - reference: PMID:26091072
    reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Ihh and Pthrp mRNA levels were increased in Fgfr3-deficient chondrocytes
    explanation: Primary-cell evidence of the Hedgehog/PTHrP response.
  downstream:
  - target: Chondroma-like Lesion Formation
    causal_link_type: DIRECT

- name: Enhanced Canonical Wnt Signaling
  description: Mutant zebrafish cranial skeleton shows increased active beta-catenin and axin2 expression. Wnt inhibition partly improves cartilage architecture. The molecular connection from FGFR3 loss to Wnt activation, and whether IHH mediates it, remain unresolved; a direct serial IHH-to-Wnt mechanism is not established.
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:32641982
    reference_title: Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the level of non-phosphorylated β-catenin (activated-β-catenin) was remarkably up-regulated in fgfr3 mutants
    explanation: Direct signaling measurement in zebrafish head skeleton.
  biological_processes:
  - preferred_term: canonical Wnt signaling pathway
    term:
      id: GO:0060070
      label: canonical Wnt signaling pathway
    modifier: INCREASED
  downstream:
  - target: Disordered Growth Plate Architecture
    description: Partial pharmacological rescue supports a contribution to cartilage disorganization in fish.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Increased Growth Plate Chondrocyte Proliferation
  description: Fgfr3 deletion increases growth-plate chondrocyte proliferation in mouse and zebrafish models, contributing to increased cartilage output. This is distinct from cell hypertrophy and from the reduced proliferation of cranial osteoblasts in mutant fish.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:26091072
    reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: showed an irregular distribution in the proliferative and hypertrophic zones in mutants and had higher rates of proliferation
    explanation: PCNA/Ki67 findings in mutant mouse growth plates.
  cell_types:
  - preferred_term: growth plate cartilage chondrocyte
    term:
      id: CL:1000217
      label: growth plate cartilage chondrocyte
  biological_processes:
  - preferred_term: growth plate cartilage chondrocyte proliferation
    term:
      id: GO:0003419
      label: growth plate cartilage chondrocyte proliferation
    modifier: INCREASED
  downstream:
  - target: Endochondral Bone and Vertebral Overgrowth
    description: Greater chondrocyte output contributes to longitudinal growth.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Increased Chondrocyte Hypertrophy
  description: Growth plates expand their hypertrophic compartment after Fgfr3 loss. In conditional mice, hypertrophic and terminal differentiation markers increase; fish cartilage contains abnormally enlarged cells. This model-supported mechanism contributes to cartilage overgrowth and architectural disruption.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:26091072
    reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Immunoreactivity for these markers was increased in Fgfr3 cKO relative to control mice
    explanation: Increased collagen X and MMP13 staining supports altered hypertrophic differentiation.
  - reference: PMID:32641982
    reference_title: Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the proportion of chondrocytes with abnormally enlarged volume and hypertrophy was increased significantly in fgfr3 mutants
    explanation: Fish chondrocyte enlargement measured histologically.
  cell_types:
  - preferred_term: hypertrophic chondrocyte
    term:
      id: CL:0000743
      label: hypertrophic chondrocyte
  biological_processes:
  - preferred_term: chondrocyte hypertrophy
    term:
      id: GO:0003415
      label: chondrocyte hypertrophy
    modifier: INCREASED
  downstream:
  - target: Endochondral Bone and Vertebral Overgrowth
    description: Expanded hypertrophic output contributes to endochondral elongation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Disordered Growth Plate Architecture
    description: Hypertrophy and architectural disorganization coexist in the mutant growth plate; the experiment does not establish a direct causal step between them.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Disordered Growth Plate Architecture
  description: Conditional Fgfr3 loss disrupts columnar organization and chondrocyte polarity, including primary-cilium orientation, in mouse growth plates. Mutant fish also show disordered chondrocyte arrangement and cartilage collagen organization. These structural abnormalities can contribute to cartilage dysplasia and chondroma-like lesions.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:26091072
    reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: growth plates in mutants were expanded and the columnar morphology of chondrocytes was lost
    explanation: Direct histology of disordered mouse growth plates.
  - reference: PMID:32641982
    reference_title: Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the collagen fibers lost its symmetry with disrupted organization in fgfr3 mutant chondrocytes
    explanation: Cartilage-matrix organization in fish.
  locations:
  - preferred_term: growth plate cartilage
    term:
      id: UBERON:0004129
      label: growth plate cartilage
  downstream:
  - target: Chondroma-like Lesion Formation
    description: Disorganized growth plates accompany the formation of ectopic cartilage masses.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Reduced Hypertrophic Chondrocyte Apoptosis
  description: 'Hypertrophic-zone apoptosis is reduced in conditional mutant mice, which may contribute to cell accumulation and cartilage lesions. This effect depends on tissue context: isolated primary chondrocytes did not show the same basal apoptosis difference.'
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:26091072
    reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the proportion of TUNEL-positive cells relative to the total number of hypertrophic chondrocytes was significantly reduced in mutants as compared to control mice
    explanation: In vivo apoptosis result.
  - reference: PMID:26091072
    reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: In primary chondrocytes isolated from Fgfr3 cKO mice, the proportion of TUNEL-positive cells was similar to control levels
    explanation: The isolated-cell result limits generalization of the in vivo apoptosis defect.
  cell_types:
  - preferred_term: hypertrophic chondrocyte
    term:
      id: CL:0000743
      label: hypertrophic chondrocyte
  downstream:
  - target: Chondroma-like Lesion Formation
    description: Reduced clearance may contribute to cell accumulation; this contribution was not isolated experimentally.
    causal_link_type: UNKNOWN
- name: Endochondral Bone and Vertebral Overgrowth
  biological_scale: TISSUE
  role: consequence
  mechanism_confidence: ESTABLISHED
  description: >-
    Increased growth-plate output lengthens long bones and vertebral bodies. Human radiographs show tall vertebrae and broad femoral metaphyses with long shafts. Altered vertebral growth may contribute to spinal deformity, but the mechanical sequence has not been established in patients. The disease is not restricted categorically to endochondral bones: cranial findings and fish intramembranous-ossification defects require separate consideration.
  locations:
  - preferred_term: growth plate cartilage
    term:
      id: UBERON:0004129
      label: growth plate cartilage
  biological_processes:
  - preferred_term: endochondral bone growth
    term:
      id: GO:0003416
      label: endochondral bone growth
    modifier: INCREASED
  evidence:
  - reference: PMID:8601314
    reference_title: "Fibroblast growth factor receptor 3 is a negative regulator of bone growth."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: "We have identified a role for fibroblast growth factor receptor 3 (FGFR-3) in this process by disrupting the murine Fgfr-3 gene to produce severe and progressive bone dysplasia with enhanced and prolonged endochondral bone growth."
    explanation: Establishes enhanced and prolonged endochondral growth as the tissue-level result of losing the receptor.
    quote_role: PRIMARY_RESULT
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: "Radiographic findings included tall vertebral bodies with irregular borders and broad femoral metaphyses with long tubular shafts"
    explanation: The human radiographic counterpart of the mouse overgrowth phenotype.
    quote_role: PRIMARY_RESULT
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: "These findings indicate that abnormal FGFR3 signaling can cause human anomalies by promoting as well as inhibiting endochondral bone growth."
    explanation: States the bidirectional axis that makes this entry the counterpart of the achondroplasia group.

    quote_role: PRIMARY_RESULT
  downstream:
  - target: Tall Stature
    description: Long-bone elongation contributes to increased stature.
    causal_link_type: DIRECT
  - target: Tall Vertebral Bodies
    description: Increased vertebral length is the corresponding radiographic feature.
    causal_link_type: DIRECT
  - target: Scoliosis
    description: Altered vertebral growth is proposed to predispose to spinal curvature; precise human biomechanics remain untested.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:8630492
      reference_title: "Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: "Skeletal defects include kyphosis, scoliosis, crooked tails and curvature and overgrowth of long bones and vertebrae."
      explanation: >-
        Fgfr3-null mice develop scoliosis and kyphosis together with vertebral
        overgrowth. INDIRECT because the human spinal curvature is inferred from
        the mouse co-occurrence, not measured as a consequence of vertebral growth.
  - target: Tibial Bowing
    description: >-
      Fgfr3-null mice show curvature as well as overgrowth of long bones, the
      model counterpart of the bowed tibiae and fibulae of the homozygous
      Thr546Lys brothers. The human deformity has not been traced to a specific
      growth-plate process.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:8630492
      reference_title: "Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: "Skeletal defects include kyphosis, scoliosis, crooked tails and curvature and overgrowth of long bones and vertebrae."
      explanation: >-
        Long-bone curvature accompanies long-bone overgrowth in the null mouse;
        the link to human tibial bowing is by analogy.
  - target: Wide Femoral Metaphysis
    description: Altered endochondral growth produces broad metaphyses in the human radiographic phenotype.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Arachnodactyly
    description: Elongated digital bones contribute to long slender digits.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Reduced Cranial Osteoblast Differentiation
  description: Fgfr3-mutant zebrafish have reduced osteoblast differentiation-marker expression and fewer proliferating Osterix-positive cells in the head skeleton. This cranial model phenotype differs from increased growth-plate chondrocyte proliferation; its contribution to human cranial findings remains inferred.
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:32641982
    reference_title: Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the expressions of col1a2, osteopontin (spp1), osteonectin (osn), which were the later markers of osteoblast differentiation, were decreased in fgfr3 mutants
    explanation: Reduced osteoblast differentiation-marker expression in fish.
  biological_processes:
  - preferred_term: osteoblast differentiation
    term:
      id: GO:0001649
      label: osteoblast differentiation
    modifier: DECREASED
  downstream:
  - target: Delayed Cranial Ossification
    description: Reduced osteoblast maturation contributes to delayed cranial mineralization.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Delayed Cranial Ossification
  description: Fgfr3-mutant zebrafish show delayed cranial mineralization, persistent sutures and separate small bone islands. These findings offer a model for sutural abnormalities such as human Wormian bones; they do not establish a cause of intellectual disability or all human microcephaly. Wnt inhibition did not significantly restore intramembranous ossification.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:32641982
    reference_title: Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Both the frontal suture and coronal suture were not closed even at adult stage in fgfr3 mutants.
    explanation: Delayed suture closure in fish.
  - reference: PMID:32641982
    reference_title: Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the delayed intramembranous ossification of opercle and branchiostegal rays was not significantly changed in XAV939-treated mutants
    explanation: Negative treatment readout distinct from improved cartilage architecture.
  biological_processes:
  - preferred_term: bone mineralization
    term:
      id: GO:0030282
      label: bone mineralization
    modifier: DECREASED
  downstream:
  - target: Wormian Bones
    description: Separate cranial bone islands in fish resemble the human sutural-bone phenotype.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Chondroma-like Lesion Formation
  biological_scale: TISSUE
  role: consequence
  mechanism_confidence: PROVISIONAL
  description: >-
    Disordered growth plates lacking FGFR3 generate enchondroma- and
    osteochondroma-like cartilage lesions in mice. Several members of the Utah
    pedigree had a solitary osteochondroma of the femur, tibia or a phalanx,
    which is the human observation this node is anchored to. The link between the
    two is not established: the human lesions are solitary and were not examined
    for hedgehog activity, while the mouse lesions are multiple and mechanistically
    dissected, so the node records a plausible correspondence rather than a
    demonstrated one.
  evidence:
  - reference: PMID:26091072
    reference_title: "FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: "we found that postnatal chondrocyte-specific Fgfr3 deletion induced multiple chondroma-like lesions, including enchondromas and osteochondromas, adjacent to disordered growth plates."
    explanation: The model-system observation of cartilage lesions arising from Fgfr3 loss.
    quote_role: PRIMARY_RESULT
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: "Several affected individuals had a single osteochondroma of the femur, the tibia, or a phalanx"
    explanation: >-
      The human counterpart. Graded INDIRECT because the report records the
      lesions without linking them to FGFR3 signaling in those individuals.

    quote_role: PRIMARY_RESULT
  downstream:
  - target: Osteochondroma
    description: Mouse cartilage lesions partly resemble the solitary human lesions; pathway identity has not been tested in patients.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Failure of Cochlear Pillar Cell Differentiation
  biological_scale: CELLULAR
  role: consequence
  mechanism_confidence: PROVISIONAL
  description: >-
    Fgfr3-null mice fail to develop inner pillar cells, while outer pillar-cell differentiation stalls and the tunnel of Corti fails to form. This provides a model-based explanation for human sensorineural hearing loss, but normal clinical CT/MRI does not demonstrate a pillar-cell defect in patients. Human hearing severity ranges from mild to severe and is not invariably profound.
  locations:
  - preferred_term: organ of Corti
    term:
      id: UBERON:0002227
      label: spiral organ of cochlea
  cell_types:
  - preferred_term: Cochlear pillar cell
    term:
      id: CL:1000191
      label: pillar cell
  biological_processes:
  - preferred_term: inner ear morphogenesis
    term:
      id: GO:0042472
      label: inner ear morphogenesis
    modifier: ABNORMAL
  evidence:
  - reference: PMID:8630492
    reference_title: "Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: "Inner ear defects include failure of pillar cell differentiation and tunnel of Corti formation and result in profound deafness."
    explanation: The cellular lesion behind the hearing loss, demonstrated in the null mouse.
    quote_role: PRIMARY_RESULT
  - reference: PMID:17117437
    reference_title: Loss of Fgfr3 leads to excess hair cell development in the mouse organ of Corti.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the inner pillar cell never develops, while the outer pillar cell is stalled in its differentiation
    explanation: Distinguishes the two pillar-cell developmental abnormalities in null mice.
  downstream:
  - target: Sensorineural Hearing Loss
    description: Pillar/tunnel disruption causes mouse deafness and is a proposed substrate of human hearing loss.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Altered Cochlear Sensory Epithelial Patterning
  description: Fgfr3-null mice develop an additional row of outer hair cells and accompanying Deiters cells in the apical two thirds of the organ of Corti. FGFR3 therefore regulates sensory/supporting-cell patterning as well as pillar-cell differentiation. The relative contribution of each lesion to hearing loss has not been separated in human CATSHL.
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:17117437
    reference_title: Loss of Fgfr3 leads to excess hair cell development in the mouse organ of Corti.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: we found an extra row of outer hair cells, and accompanying Deiters' cells, in the apical two thirds of the organ of Corti in the Fgfr3 mutant.
    explanation: Direct mouse cochlear patterning result.
  locations:
  - preferred_term: spiral organ of cochlea
    term:
      id: UBERON:0002227
      label: spiral organ of cochlea
  downstream:
  - target: Sensorineural Hearing Loss
    description: Abnormal epithelial patterning accompanies deafness in Fgfr3-null mice; its independent contribution is unresolved.
    causal_link_type: UNKNOWN
phenotypes:
- category: Growth
  name: Tall Stature
  description: >-
    Marked postnatal overgrowth is characteristic but variable. In the Utah adult subset, 13/14 measured adults exceeded the 97th centile; one woman was between the 75th and 97th centiles. The Italian proband had normal birth length with growth above the 97th centile from infancy. Average stature was reported in an additional candidate spectrum case with homozygous Asn540Asp.
  phenotype_term:
    preferred_term: Tall stature
    term:
      id: HP:0000098
      label: Tall stature
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Adult height in males was >97th percentile in 5 of 5 men, with a mean height of 77 inches, and adult height in females was >75th percentile in 9 of 9 and >97th percentile in 8 of 9 women, with a mean height of 70 inches."
    explanation: Gives per-sex counts above the 97th and 75th centiles, supporting a VERY_FREQUENT band.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  phenotype_contexts:
  - population: Clinically studied members of the founding Utah pedigree
    frequency: VERY_FREQUENT
    notes: 13/14 in the reported family subset; not a population penetrance estimate.
    evidence:
    - reference: PMID:17033969
      reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Adult height in males was >97th percentile in 5 of 5 men, with a mean height of 77 inches, and adult height in females was >75th percentile in 9 of 9 and >97th percentile in 8 of 9 women, with a mean height of 70 inches."
      explanation: Gives per-sex counts above the 97th and 75th centiles, supporting a VERY_FREQUENT band.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
- category: Musculoskeletal
  name: Camptodactyly
  description: >-
    Fixed flexion contracture of the digits. Bound to the pooled term because the
    published count is of hands and/or feet together, so a finger-specific term
    would carry a denominator that is not finger-specific.
  phenotype_term:
    preferred_term: Camptodactyly
    term:
      id: HP:0012385
      label: Camptodactyly
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "was present in 18 (90%) of 20 individuals, and 17 (85%) of 20 had hearing loss"
    explanation: 90% of genotyped individuals had camptodactyly, supporting VERY_FREQUENT.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  phenotype_contexts:
  - population: Clinically studied members of the founding Utah pedigree
    frequency: VERY_FREQUENT
    notes: 18/20 in the reported family subset; not a population penetrance estimate.
    evidence:
    - reference: PMID:17033969
      reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "was present in 18 (90%) of 20 individuals, and 17 (85%) of 20 had hearing loss"
      explanation: 90% of genotyped individuals had camptodactyly, supporting VERY_FREQUENT.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
- category: Musculoskeletal
  name: Camptodactyly of Toe
  description: >-
    The same digital contracture in the feet; the original series counted hand
    and/or foot involvement together rather than separately.
  phenotype_term:
    preferred_term: Camptodactyly of toe
    term:
      id: HP:0001836
      label: Camptodactyly of toe
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Camptodactyly of the hands and/or feet"
    explanation: >-
      Records foot involvement. No frequency is given because the published count
      pools hands and feet, so no toe-specific denominator exists.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Auditory
  name: Sensorineural Hearing Loss
  description: >-
    All formally tested affected members of the Utah pedigree had bilateral sensorineural hearing loss with absent otoacoustic emissions. Fourteen of 20 had documented hearing loss and three additional relatives reported hearing loss without formal testing; 17/20 therefore describes any reported/documented loss, not 17 proven bilateral sensorineural cases. Onset ranged from congenital/early infancy in that family to childhood in later reports; progression was variable, and severity ranged from mild to severe.
  phenotype_term:
    preferred_term: Bilateral sensorineural hearing impairment
    term:
      id: HP:0008619
      label: Bilateral sensorineural hearing impairment
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "On audiological exam, each tested individual had bilateral sensorineural hearing loss and absent otoacoustic emissions"
    explanation: Establishes the sensorineural character and the absent otoacoustic emissions.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "By report, the hearing loss was congenital or developed in early infancy, progressed variably in early childhood, and ranged from mild to severe."
    explanation: Infantile onset and variable early progression in the founding pedigree; later families expand onset into childhood.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:37990933
    reference_title: CATSHL syndrome, a new family and phenotypic expansion.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: We report the case of a 12-year-old girl and her father who both had marked postnatal tall stature, camptodactyly and clinodactyly, scoliosis and juvenile-onset hearing loss.
    explanation: Childhood-onset hearing loss in the Arg621Cys family broadens onset beyond infancy.
- category: Musculoskeletal
  name: Scoliosis
  description: >-
    Spinal curvature can progress to severe thoracolumbar kyphoscoliosis. The Utah series included an approximately 80-degree lumbar curvature; the Arg621Cys father underwent spinal surgery at 23 years. Altered skeletal growth may contribute, but the precise biomechanical sequence is not established.
  phenotype_term:
    preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "pectus abnormalities; and/or severe thoracolumbar kyphoscoliosis"
    explanation: Records the severe end of the spinal phenotype.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  review_notes: >-
    Bound to HP:0002650 Scoliosis rather than HP:0002751 Kyphoscoliosis to match
    the node name and the general finding; the source's "severe thoracolumbar
    kyphoscoliosis" describes the severe end rather than every affected
    individual. No frequency band: the source says several individuals were
    affected and then states the frequency "might be underestimated because many
    family members elected not to undergo chest and/or spine examination", so no
    denominator is available and a band would be a guess.
- category: Musculoskeletal
  name: Pectus Excavatum
  description: >-
    Anterior chest wall depression, reported in the Utah pedigree and listed
    among the recognised features of the syndrome.
  phenotype_term:
    preferred_term: Pectus excavatum
    term:
      id: HP:0000767
      label: Pectus excavatum
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Several had scoliosis and/or a pectus excavatum"
    explanation: The primary report of the finding in the founding pedigree.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Neurologic
  name: Intellectual Disability
  description: >-
    Intellectual disability is reported in the founding family. The published 12/20 figure combines developmental delay and/or intellectual disability and cannot be assigned to either phenotype separately. Normal intellectual and social development was documented in the Italian Arg621Cys proband.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of 20 individuals, 12 (60%) had developmental delay and/or mental retardation, and several of these had microcephaly (head circumference <2nd percentile)."
    explanation: The combined 12/20 developmental-delay and/or intellectual-disability count establishes occurrence but cannot yield a separate frequency for this phenotype.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Her intellectual and social development was nor-mal.
    explanation: 'Cannova et al., Clinical Genetics 2024: normal development in the 12-year-old proband demonstrates variability.'
- category: Neurologic
  name: Neurodevelopmental Delay
  description: >-
    Developmental delay is included in the combined 12/20 developmental-delay and/or intellectual-disability observation in the Utah pedigree. The source does not provide a separate developmental-delay denominator or establish delay in multiple domains.
  phenotype_term:
    preferred_term: Neurodevelopmental delay
    term:
      id: HP:0012758
      label: Neurodevelopmental delay
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of 20 individuals, 12 (60%) had developmental delay and/or mental retardation, and several of these had microcephaly (head circumference <2nd percentile)."
    explanation: The combined 12/20 developmental-delay and/or intellectual-disability count establishes occurrence but cannot yield a separate frequency for this phenotype.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Craniofacial
  name: High Palate
  description: >-
    High-arched palate has been summarized among reported CATSHL craniofacial findings. A developmental relationship with altered craniofacial cartilage is suggested by fish models but is not demonstrated in patient tissue.
  phenotype_term:
    preferred_term: High palate
    term:
      id: HP:0000218
      label: High palate
  evidence:
  - reference: PMID:32641982
    reference_title: "Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other clinical features of CATSHL syndrome include microcephaly, wormian skull bones, a high palate, pectus excavatum"
    explanation: >-
      The zebrafish paper's introduction enumerates the human clinical features
      drawn from the three case reports. Graded HUMAN_CLINICAL because the
      sentence describes patients, not the fish. No frequency band: the sentence
      is a feature list with no denominators.
    quote_role: BACKGROUND
    directness: DIRECT
- category: Craniofacial
  name: Wormian Bones
  description: >-
    Supernumerary sutural skull bones have been reported, including in the homozygous Thr546Lys family. Irregular cranial bone islands in mutant fish offer a partial anatomical analogue.
  phenotype_term:
    preferred_term: Wormian bones
    term:
      id: HP:0002645
      label: Wormian bones
  evidence:
  - reference: PMID:32641982
    reference_title: "Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "microcephaly, wormian skull bones, a high palate"
    explanation: >-
      Same feature list. Graded HUMAN_CLINICAL for the same reason; no
      denominator, so no frequency band.
    quote_role: BACKGROUND
    directness: DIRECT
- category: Neurologic
  name: Microcephaly
  description: >-
    Absolute microcephaly, with head circumference below the 2nd centile, occurred in several members of the founding family with developmental delay or intellectual disability. This is distinct from the relative microcephaly described in the very tall Italian proband, whose head circumference was within the normal range.
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "several of these had microcephaly (head circumference <2nd percentile)"
    explanation: >-
      Documents microcephaly with its measurement threshold. No frequency band -
      "several" of the 12 delayed individuals gives no usable denominator.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Musculoskeletal
  name: Osteochondroma
  description: >-
    Solitary benign cartilage-capped bone lesion of the femur, tibia or a
    phalanx.
  phenotype_term:
    preferred_term: Osteochondroma
    term:
      id: HP:0030431
      label: Osteochondroma
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Several affected individuals had a single osteochondroma of the femur, the tibia, or a phalanx"
    explanation: Records the lesion and its sites; no denominator is given, so no frequency band.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Skeletal
  name: Tall Vertebral Bodies
  description: >-
    Increased vertebral body height with irregular borders on radiographs - the
    axial-skeleton counterpart of the long-bone overgrowth.
  phenotype_term:
    preferred_term: Increased vertebral height
    term:
      id: HP:0004570
      label: Increased vertebral height
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Radiographic findings included tall vertebral bodies with irregular borders"
    explanation: Direct radiographic description of the vertebral phenotype.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Skeletal
  name: Wide Femoral Metaphysis
  description: >-
    Broad femoral metaphyses with long tubular shafts.
  phenotype_term:
    preferred_term: Wide femoral metaphysis
    term:
      id: HP:0006417
      label: Wide femoral metaphysis
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "broad femoral metaphyses with long tubular shafts"
    explanation: Direct radiographic description of the metaphyseal phenotype.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Musculoskeletal
  name: Arachnodactyly
  description: >-
    Long slender digits, reported in the two brothers homozygous for p.Thr546Lys.
  phenotype_term:
    preferred_term: Arachnodactyly
    term:
      id: HP:0001166
      label: Arachnodactyly
  evidence:
  - reference: PMID:24864036
    reference_title: "A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The clinical picture is characterized by tall stature and severe skeletal abnormalities leading to inability to walk, with camptodactyly, arachnodactyly, and scoliosis."
    explanation: Reports arachnodactyly in the biallelic family.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Musculoskeletal
  name: Loss of Ambulation
  description: >-
    Inability to walk due to severe lower-limb skeletal deformity was reported in the homozygous Thr546Lys brothers. Comparison with different heterozygous alleles in other families does not isolate an allele-dose effect.
  phenotype_term:
    preferred_term: Inability to walk
    term:
      id: HP:0002540
      label: Inability to walk
  evidence:
  - reference: PMID:24864036
    reference_title: "A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "severe skeletal abnormalities leading to inability to walk"
    explanation: Records loss of ambulation in the homozygous brothers.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- category: Dental
  name: Peg-Shaped Incisors
  description: >-
    Peg-shaped incisors were reported in the Italian Arg621Cys proband and absent in her affected father. This single-family observation suggests phenotypic overlap with LADD syndrome; it does not establish a frequent CATSHL feature.
  phenotype_term:
    preferred_term: Conical incisor
    term:
      id: HP:0011065
      label: Conical incisor
  evidence:
  - reference: PMID:37990933
    reference_title: "CATSHL syndrome, a new family and phenotypic expansion."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Interestingly, peg-shaped incisors were observed in the proband, a feature never reported in CATSHL but typical of another FGFR3-related condition, LADD (Lacrimo - Auricolo - Dento - Digital) syndrome."
    explanation: >-
      Records the finding and the authors' own caveat that it had never been
      reported in CATSHL before.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: Multicystic Kidney Dysplasia
  category: Renal
  description: Unilateral right multicystic dysplastic kidney was observed prenatally in the Arg621Cys proband and subsequently atrophied. A single observation supports a possible phenotype expansion, with uncertain specificity.
  phenotype_term:
    preferred_term: Multicystic kidney dysplasia
    term:
      id: HP:0000003
      label: Multicystic kidney dysplasia
  evidence:
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Pregnancy was uneventful, except for dysplastic multicystic right kidney
    explanation: Cannova et al., Clinical Genetics 2024. Unilateral right multicystic dysplastic kidney was observed prenatally in the Arg621Cys proband and subsequently atrophied. A single observation supports a possible phenotype expansion, with uncertain specificity.
- name: Clinodactyly
  category: Musculoskeletal
  description: Finger clinodactyly occurred in both Italian Arg621Cys family members; the proband also had bilateral fifth-toe clinodactyly.
  phenotype_term:
    preferred_term: Clinodactyly
    term:
      id: HP:0030084
      label: Clinodactyly
  evidence:
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She also had clinodactyly and proximal placement of the fifth toes bilaterally
    explanation: Cannova et al., Clinical Genetics 2024. Finger clinodactyly occurred in both Italian Arg621Cys family members; the proband also had bilateral fifth-toe clinodactyly.
- name: Genu Valgum
  category: Musculoskeletal
  description: Valgus knees were recorded in the Arg621Cys proband and in other ascertained families.
  phenotype_term:
    preferred_term: Genu valgum
    term:
      id: HP:0002857
      label: Genu valgum
  evidence:
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She also had val-gus knees and flat feet.
    explanation: Cannova et al., Clinical Genetics 2024. Valgus knees were recorded in the Arg621Cys proband and in other ascertained families.
- name: Pes Planus
  category: Musculoskeletal
  description: Flat feet were documented in the Arg621Cys proband.
  phenotype_term:
    preferred_term: Pes planus
    term:
      id: HP:0001763
      label: Pes planus
  evidence:
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She also had val-gus knees and flat feet.
    explanation: Cannova et al., Clinical Genetics 2024. Flat feet were documented in the Arg621Cys proband.
- name: Joint Hypermobility
  category: Musculoskeletal
  description: Mild joint hyperextensibility with a Beighton score of 5/9 was described in the Arg621Cys proband.
  phenotype_term:
    preferred_term: Joint hypermobility
    term:
      id: HP:0001382
      label: Joint hypermobility
  evidence:
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: She showed mild joint hyperextensibility with Beighton score of 5/9
    explanation: Cannova et al., Clinical Genetics 2024. Mild joint hyperextensibility with a Beighton score of 5/9 was described in the Arg621Cys proband.
- name: Bifid Uvula
  category: Craniofacial
  description: A bifid uvula was one of the mild dysmorphic findings in the Arg621Cys proband.
  phenotype_term:
    preferred_term: Bifid uvula
    term:
      id: HP:0000193
      label: Bifid uvula
  evidence:
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: small ears, bifid uvula and peg-shaped incisors.
    explanation: Cannova et al., Clinical Genetics 2024. A bifid uvula was one of the mild dysmorphic findings in the Arg621Cys proband.
- name: Deeply Set Eyes
  category: Craniofacial
  description: Deeply set eyes were described in the Arg621Cys proband, without evidence of a syndrome-wide frequency.
  phenotype_term:
    preferred_term: Deeply set eye
    term:
      id: HP:0000490
      label: Deeply set eye
  evidence:
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: deeply set eyes, slight prognathism, small ears, bifid uvula
    explanation: Cannova et al., Clinical Genetics 2024. Deeply set eyes were described in the Arg621Cys proband, without evidence of a syndrome-wide frequency.
- name: High Anterior Hairline
  category: Craniofacial
  description: A high frontal hairline was described in the Arg621Cys proband.
  phenotype_term:
    preferred_term: High anterior hairline
    term:
      id: HP:0009890
      label: High anterior hairline
  evidence:
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: Mild dysmorphic features include high frontal hairline
    explanation: Cannova et al., Clinical Genetics 2024. A high frontal hairline was described in the Arg621Cys proband.
- name: Coxa Valga
  category: Musculoskeletal
  description: Right coxa valga was recorded in the 2016 proband; this annotation uses the ClinGen expert abstraction because the primary full text was unavailable.
  phenotype_term:
    preferred_term: Coxa valga
    term:
      id: HP:0002673
      label: Coxa valga
  evidence:
  - reference: url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d
    reference_title: curation results for Gene-Disease Validity
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: right coxa valga of the right femoral neck
    explanation: Right coxa valga was recorded in the 2016 proband; this annotation uses the ClinGen expert abstraction because the primary full text was unavailable.
- name: Accelerated Skeletal Maturation
  category: Musculoskeletal
  description: Carpal bone age was four years ahead of chronological age in the Italian proband; this is a single-case observation.
  phenotype_term:
    preferred_term: Accelerated skeletal maturation
    term:
      id: HP:0005616
      label: Accelerated skeletal maturation
  evidence:
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: carpal x-ray revealed a bone age 4 years older than chronological age.
    explanation: Cannova et al., Clinical Genetics 2024. Carpal bone age was four years ahead of chronological age in the Italian proband; this is a single-case observation.
- name: Small Ears
  category: Craniofacial
  description: Small ears were described among mild dysmorphic findings in the Italian proband.
  phenotype_term:
    preferred_term: Microtia
    term:
      id: HP:0008551
      label: Microtia
  evidence:
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: small ears, bifid uvula and peg-shaped incisors.
    explanation: Cannova et al., Clinical Genetics 2024. Small ears were described among mild dysmorphic findings in the Italian proband.
- name: Tibial Bowing
  category: Skeletal
  description: Severe anterior and lateral bowing of the lower-leg bones was reported in the homozygous Thr546Lys brothers. This annotation uses ClinGen expert abstraction of the primary case report.
  phenotype_term:
    preferred_term: Tibial bowing
    term:
      id: HP:0002982
      label: Tibial bowing
  evidence:
  - reference: url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d
    reference_title: curation results for Gene-Disease Validity
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: deformed bowed tibiae and fibulae, arachnodactyly, wormian bones
    explanation: ClinGen summarizes the radiographic findings of Makrythanasis et al.
  - reference: PMID:24864036
    reference_title: "A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: INDIRECT
    snippet: "The clinical picture is characterized by tall stature and severe skeletal abnormalities leading to inability to walk"
    explanation: >-
      Primary report of the severe skeletal deformity in the homozygous
      brothers. INDIRECT because the quoted abstract sentence does not name the
      tibia; the lateral tibial deviation appears in the paper's title and in
      ClinGen's abstraction of the full report.
  sequelae:
  - target: Loss of Ambulation
    causal_link_type: DIRECT
    description: >-
      In the homozygous Thr546Lys brothers the severe lower-limb deformity is
      reported as the cause of their inability to walk.
    evidence:
    - reference: PMID:24864036
      reference_title: "A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: "severe skeletal abnormalities leading to inability to walk"
      explanation: >-
        The report attributes the inability to walk to severe skeletal
        abnormalities in general, which also include scoliosis. INDIRECT because
        assigning it to the tibial deformity relies on the paper's title rather
        than on the quoted sentence.
genetic:
- name: FGFR3
  gene_term:
    preferred_term: FGFR3
    term:
      id: hgnc:3690
      label: FGFR3
  relationship_type: UNKNOWN
  notes: >-
    ClinGen classifies the semidominant FGFR3-CATSHL relationship as Moderate (reevaluation 24 August 2026). Classic pedigrees involve Arg621His, Arg621Cys and homozygous Thr546Lys. Additional missense observations from tall-stature and hearing-loss cohorts broaden the candidate spectrum but do not establish equal clinical or mechanistic certainty for every allele. The evidence supports a reported relationship whose definitive validity has not yet been established.
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We mapped the locus causing a novel disorder characterized by camptodactyly, tall stature, scoliosis, and hearing loss (CATSHL syndrome) to chromosome 4p."
    explanation: Establishes the 4p locus that contains FGFR3 and led to the gene assignment.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  variants:
  - name: c.1862G>A (p.Arg621His)
    description: >-
      Heterozygous c.1862G>A (p.Arg621His), the founding Utah allele, was identified in all 20 tested affected relatives and subsequently reported in an independent family. The original paper contains a reversed amino-acid wording in one sentence; the consistent HGVS identity is Arg621His.
    evidence:
    - reference: PMID:17033969
      reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "we screened FGFR3 and subsequently identified a heterozygous missense mutation that is predicted to cause a p.R621H substitution in the tyrosine kinase domain and partial loss of FGFR3 function."
      explanation: Names the allele and its predicted functional consequence.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
    - reference: url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d
      reference_title: curation results for Gene-Disease Validity
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      directness: DIRECT
      snippet: '(p.Arg621His) ... ClinGen Allele Registry: ... CA126386 ... Monoallelic heterozygous'
      explanation: ClinGen records the recurrent allele in both Toydemir and Escobar probands.
  - name: c.1861C>T (p.Arg621Cys)
    description: >-
      Heterozygous c.1861C>T (p.Arg621Cys), reported using NM_000142.5 in an Italian father and daughter; classified likely pathogenic by the report. Clinical overlap with LADD remains a phenotype-boundary question.
    evidence:
    - reference: PMID:37990933
      reference_title: "CATSHL syndrome, a new family and phenotypic expansion."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "molecular analysis revealed a hitherto unreported, monoallelic variant c.1861C>T (p.Arg621Cys) in FGFR3."
      explanation: Names the second dominant allele at Arg621.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
  - name: c.1637C>A (p.Thr546Lys)
    description: >-
      Homozygous NM_000142.4:c.1637C>A (p.Thr546Lys) in two Egyptian brothers with severe lower-limb deformity. Subtle parental skeletal features are described in ClinGen; the report does not provide a controlled dosage comparison with the Arg621 alleles.
    evidence:
    - reference: PMID:24864036
      reference_title: "A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Whole exome sequencing revealed a homozygous novel missense mutation in the FGFR3 gene in exon 12 (NM_000142.4:c.1637C>A: p.(Thr546Lys))."
      explanation: Names the biallelic allele with its transcript-level description.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
  - name: c.1618A>G (p.Asn540Asp)
    description: Homozygous candidate spectrum variant in Brazilian proband RC-26 with prelingual mild-to-moderate hearing loss, camptodactyly and microcephaly but average stature. The authors considered it likely pathogenic/causative, while their table records VUS or LP/VUS database assessments. No functional assay was reported; this observation does not establish classic CATSHL or a universal loss-of-function effect for substitutions at residue 540.
    evidence:
    - reference: PMID:39498320
      reference_title: 'Genetic heterogeneity in autosomal recessive hearing loss: a survey of Brazilian families.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Proband RC-26 had a likely pathogenic variant in homozygosis in FGFR3
      explanation: Authors report a candidate homozygous FGFR3 finding; pathogenicity and the syndrome boundary remain uncertain.
    - reference: PMID:39498320
      reference_title: 'Genetic heterogeneity in autosomal recessive hearing loss: a survey of Brazilian families.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Height was average and flexion restriction of the third digit was observed in both hands.
      explanation: The case lacks the characteristic tall stature of classic CATSHL.
  - name: c.1541C>A (p.Ala514Asp)
    description: A heterozygous finding in the 2024 familial-tall-stature study, included with low case-level weight in the 2026 ClinGen reevaluation. These broader growth-phenotype cases do not establish the complete CATSHL triad or an experimentally measured receptor loss-of-function effect.
    evidence:
    - reference: url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d
      reference_title: curation results for Gene-Disease Validity
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      directness: DIRECT
      snippet: '(p.Ala514Asp) ... ClinGen Allele Registry: ... CA355981408 ... Monoallelic heterozygous'
      explanation: Expert abstraction of Gregorova et al. (PMID:38307035); retain as a qualified reported finding, not definitive allele causality.
    - reference: PMID:38307035
      reference_title: "Genetic Testing of Children With Familial Tall Stature: Is it Worth Doing?"
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: "The genetic cause of FTS was elucidated in 11/34 (32.4%) children ... FGFR3, CHD8, GPC3, and PPP2R5D genes"
      explanation: >-
        Primary study behind the ClinGen abstraction of p.Ala514Asp. The abstract
        counts an FGFR3 variant among the causative findings in familial tall
        stature but names neither allele and does not report the CATSHL triad;
        the allele identities come from ClinGen's abstraction of the full text.
  - name: c.1959C>A (p.Asn653Lys)
    description: A heterozygous finding in the 2024 familial-tall-stature study, included with low case-level weight in the 2026 ClinGen reevaluation. These broader growth-phenotype cases do not establish the complete CATSHL triad or an experimentally measured receptor loss-of-function effect.
    evidence:
    - reference: url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d
      reference_title: curation results for Gene-Disease Validity
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      directness: DIRECT
      snippet: '(p.Asn653Lys) ... ClinGen Allele Registry: ... CA355982647 ... Monoallelic heterozygous'
      explanation: Expert abstraction of Gregorova et al. (PMID:38307035); retain as a qualified reported finding, not definitive allele causality.
    - reference: PMID:38307035
      reference_title: "Genetic Testing of Children With Familial Tall Stature: Is it Worth Doing?"
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: "The genetic cause of FTS was elucidated in 11/34 (32.4%) children ... FGFR3, CHD8, GPC3, and PPP2R5D genes"
      explanation: >-
        Primary study behind the ClinGen abstraction of p.Asn653Lys. The abstract
        counts an FGFR3 variant among the causative findings in familial tall
        stature but names neither allele and does not report the CATSHL triad;
        the allele identities come from ClinGen's abstraction of the full text.
  gene_disease_validity:
  - validity_classification: MODERATE
    classified_by: CLINGEN
    external_id: CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d
    evidence:
    - reference: url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d
      reference_title: curation results for Gene-Disease Validity
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      directness: DIRECT
      snippet: It was reevaluated on 8/24/2026 (SOP Version 12). ... the classification remained at moderate.
      explanation: Current expert validity assessment, distinct from older web-search summaries.
animal_models:
- name: Fgfr3-null mouse
  species: Mouse
  genotype: Fgfr3 homozygous targeted disruption
  publication: PMID:8630492
  description: >-
    Constitutive Fgfr3-null mice show skeletal overgrowth and profound deafness. The skeletal and cochlear findings suggested FGFR3 as a candidate in the original human pedigree; the null genotype is not the heterozygous human missense genotype.
  modeled_mechanisms:
  - target: Endochondral Bone and Vertebral Overgrowth
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    description: >-
      Skeletal overgrowth of long bones and vertebrae with kyphosis and scoliosis,
      matching the human radiographic pattern.
    limitations: >-
      The mouse is a complete null while the common human genotype is a
      heterozygous missense allele on a wild-type background, so the mouse
      represents a more severe loss of receptor function than the dominant human
      disease.
    readouts:
    - name: Long bone and vertebral length
      target: Endochondral Bone and Vertebral Overgrowth
      direction: INCREASED
      interpretation: Structural correlate of the overgrowth node.
      evidence:
      - reference: PMID:8630492
        reference_title: "Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Skeletal defects include kyphosis, scoliosis, crooked tails and curvature and overgrowth of long bones and vertebrae."
        explanation: Reports the skeletal measurements behind this readout.
        quote_role: PRIMARY_RESULT
        directness: DIRECT
    evidence:
    - reference: PMID:8630492
      reference_title: "Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Our results demonstrate that Fgfr3 is essential for normal endochondral ossification and inner ear development."
      explanation: Supports treating the null mouse as informative for the endochondral overgrowth node.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
  - target: Failure of Cochlear Pillar Cell Differentiation
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    description: >-
      Pillar cells fail to differentiate and the tunnel of Corti does not form,
      producing profound deafness - the cellular lesion the human sensorineural
      hearing loss is attributed to.
    limitations: >-
      The mouse deafness is static while the human hearing loss is progressive.
      The original authors read that difference as evidence that residual
      wild-type FGFR3 in heterozygotes delays rather than prevents the defect,
      and as a hint that pillar cells need FGFR3 for maintenance as well as
      formation - neither of which the null mouse can test.
    readouts:
    - name: Pillar cell differentiation and tunnel of Corti formation
      target: Failure of Cochlear Pillar Cell Differentiation
      direction: ABOLISHED
      interpretation: Histological correlate of the cochlear node.
      evidence:
      - reference: PMID:8630492
        reference_title: "Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Inner ear defects include failure of pillar cell differentiation and tunnel of Corti formation and result in profound deafness."
        explanation: Reports the cochlear histology and the resulting deafness.
        quote_role: PRIMARY_RESULT
        directness: DIRECT
    evidence:
    - reference: PMID:8630492
      reference_title: "Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Fibroblast growth factor receptor 3 (Fgfr3) is a tyrosine kinase receptor expressed in developing bone, cochlea, brain and spinal cord."
      explanation: Establishes cochlear expression, which is why the null mouse is informative for this node.
      quote_role: BACKGROUND
      directness: DIRECT
  - target: Altered Cochlear Sensory Epithelial Patterning
    description: Additional supporting/hair-cell patterning defects were described on reexamination of null cochleae.
    evidence:
    - reference: PMID:17117437
      reference_title: Loss of Fgfr3 leads to excess hair cell development in the mouse organ of Corti.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: we found an extra row of outer hair cells, and accompanying Deiters' cells, in the apical two thirds of the organ of Corti in the Fgfr3 mutant.
      explanation: Mouse cochlear phenotype, not human histology.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Anatomical patterning is a model readout; human cochlear tissue was not examined.
    fidelity: MODERATE
- name: Deng Fgfr3-null skeletal model
  species: Mouse
  genotype: Homozygous targeted Fgfr3 disruption
  publication: PMID:8601314
  description: Independent constitutive knockout study establishing FGFR3 as a negative regulator of bone growth; its cited abstract focuses on skeletal rather than auditory findings.
  modeled_mechanisms:
  - target: Endochondral Bone and Vertebral Overgrowth
    description: Progressive skeletal dysplasia with prolonged endochondral bone growth.
    evidence:
    - reference: PMID:8601314
      reference_title: Fibroblast growth factor receptor 3 is a negative regulator of bone growth.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: severe and progressive bone dysplasia with enhanced and prolonged endochondral bone growth
      explanation: Direct knockout skeletal phenotype.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Complete receptor deletion does not establish the biochemical action of individual human missense alleles.
    fidelity: MODERATE
- name: Chondrocyte-specific postnatal Fgfr3 knockout mouse
  species: Mouse
  genotype: Fgfr3 floxed alleles with tamoxifen-inducible Col2a1-CreERT2
  publication: PMID:26091072
  description: >-
    Deletion induced after four weeks of age yields disorganized growth plates and multiple osteochondroma-/enchondroma-like lesions. Mosaic lesions contain mutant and unrecombined cells. Vismodegib suppresses lesion formation but also causes premature growth-plate fusion and shortened long bones.
  modeled_mechanisms:
  - target: Chondroma-like Lesion Formation
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    description: >-
      Multiple enchondroma- and osteochondroma-like lesions adjacent to
      disordered growth plates, with reduced ERK and raised IHH, and fewer
      lesions when hedgehog signaling is blocked.
    limitations: >-
      The mouse lesions are multiple and the human lesions solitary, and no
      CATSHL patient lesion has been examined for ERK or hedgehog activity, so
      the shared mechanism is inferred from the shared genotype rather than
      measured in humans.
    readouts:
    - name: Chondroma-like lesion count
      target: Chondroma-like Lesion Formation
      direction: INCREASED
      interpretation: The lesion burden that hedgehog inhibition reduces.
      evidence:
      - reference: PMID:26091072
        reference_title: "FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Importantly, treatment with an inhibitor of IHH signaling reduced the occurrence of chondroma-like lesions in Fgfr3-deficient mice."
        explanation: Reports the lesion count responding to pathway inhibition.
        quote_role: PRIMARY_RESULT
        directness: DIRECT
    evidence:
    - reference: PMID:26091072
      reference_title: "FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "This is the first study reporting that the loss of Fgfr3 function leads to the formation of chondroma-like lesions via downregulation of MEK/ERK signaling and upregulation of IHH, suggesting that FGFR3 has a tumor suppressor-like function in chondrogenesis."
      explanation: Supports treating this model as informative for the lesion node and names the proposed mechanism.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
  - target: Derepressed Indian Hedgehog Signaling
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    description: >-
      The model is where the raised IHH and lowered ERK were actually measured.
    limitations: >-
      Measured in mouse cartilage only; the equivalent measurement has never been
      made in human CATSHL tissue.
    readouts:
    - name: Indian hedgehog expression in growth plate cartilage
      target: Derepressed Indian Hedgehog Signaling
      direction: INCREASED
      interpretation: The molecular readout defining this node.
      evidence:
      - reference: PMID:26091072
        reference_title: "FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "The lesions showed decreased extracellular signal-regulated kinase (ERK) activity and increased Indian hedgehog (IHH) expression."
        explanation: The direct measurement of both pathway changes.
        quote_role: PRIMARY_RESULT
        directness: DIRECT
  - target: Disordered Growth Plate Architecture
    description: Expanded growth plates lose orderly chondrocyte columns.
    evidence:
    - reference: PMID:26091072
      reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: growth plates in mutants were expanded and the columnar morphology of chondrocytes was lost
      explanation: Conditional mouse growth-plate histology.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Multiple mouse lesions exceed the solitary osteochondromas described in the founding human family.
    fidelity: MODERATE
  - target: Chondroma-like Lesion Formation
    description: Hedgehog inhibition prevented lesion formation during the treatment window.
    evidence:
    - reference: PMID:26091072
      reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: there were no chondroma-like lesions in the mutants after 4 weeks of SMOi treatment
      explanation: Vismodegib intervention in conditional mice.
    relationship: RESCUES
    model_scale: TISSUE
    limitations: Prevention was accompanied by premature growth-plate fusion and reduced limb length; it is not established treatment of existing human lesions.
    fidelity: MODERATE
- name: fgfr3 knockout zebrafish
  species: Zebrafish
  genotype: Homozygous exon-11 frameshift deletion; 2-bp and 17-bp lines, predominantly the 17-bp line
  publication: PMID:32641982
  description: >-
    CRISPR/Cas9 AB-background mutants show craniofacial cartilage dysplasia, delayed ossification and cranial bone islands. Ceratohyal cartilage is elongated, but surviving adults have smaller overall body size, with severe jaw deformity affecting feeding. Weberian apparatus and swim bladder abnormalities suggest altered hearing; auditory function itself was not measured.
  modeled_mechanisms:
  - target: Derepressed Indian Hedgehog Signaling
    description: Head-skeleton Ihh protein is increased.
    evidence:
    - reference: PMID:32641982
      reference_title: Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Ihh protein was significantly increased in fgfr3 mutants
      explanation: Direct fish protein measurement.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: MOLECULAR
    limitations: Does not prove that IHH lies upstream of Wnt in this model.
    fidelity: MODERATE
  - target: Enhanced Canonical Wnt Signaling
    description: Active beta-catenin and axin2 are increased.
    evidence:
    - reference: PMID:32641982
      reference_title: Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: the expression level of axin2 was increased in head skeleton of fgfr3 mutants
      explanation: Wnt target-gene readout.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: MOLECULAR
    limitations: Upstream FGFR3-to-Wnt intermediates are unresolved.
    fidelity: MODERATE
  - target: Disordered Growth Plate Architecture
    description: XAV939 partly improves cartilage arrangement and hypertrophy.
    evidence:
    - reference: PMID:32641982
      reference_title: Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: The abnormal arrangement and hypertrophy of chondrocytes in ceratohyal cartilage were both alleviated in XAV939-treated mutants.
      explanation: Pharmacological partial rescue in fish.
    relationship: RESCUES
    model_scale: TISSUE
    limitations: 2.5 micromolar XAV939 from 10–20 days post fertilization; cartilage rescue was incomplete and did not significantly improve intramembranous ossification.
    fidelity: MODERATE
  - target: Delayed Cranial Ossification
    description: Intramembranous cranial bones remain poorly mineralized.
    evidence:
    - reference: PMID:32641982
      reference_title: Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Both the frontal suture and coronal suture were not closed even at adult stage in fgfr3 mutants.
      explanation: Fish cranial phenotype.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Fish cranial anatomy and body growth differ from human CATSHL; hearing loss was inferred from anatomy rather than measured.
    fidelity: MODERATE
- name: Spider lamb syndrome sheep
  species: Sheep
  genotype: Fgfr3 p.Val700Glu, naturally occurring
  publication: PMID:16441300
  description: >-
    Naturally occurring ovine hereditary chondrodysplasia caused by FGFR3 p.Val700Glu provides an inherited skeletal-overgrowth model. Homozygotes have severe deformity and heterozygotes can have increased long-bone length; genetic background modifies expression. The model does not establish human variant-specific mechanisms or a CATSHL cochlear phenotype.
  modeled_mechanisms:
  - target: Endochondral Bone and Vertebral Overgrowth
    description: Natural inherited receptor impairment is associated with skeletal elongation.
    evidence:
    - reference: PMID:16441300
      reference_title: A single-base change in the tyrosine kinase II domain of ovine FGFR3 causes hereditary chondrodysplasia in sheep.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: the mutant FGFR3 allele has an additive effect on long-bone length
      explanation: Primary ovine genetic study, replacing secondary citation through the human report.
    - reference: PMID:17032787
      reference_title: Enhanced skeletal growth of sheep heterozygous for an inactivated fibroblast growth factor receptor 3.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: At maturity, FGFR3(SLS/+) ewes exhibited a larger frame size and longer bones than normal FGFR3(+/+) ewes
      explanation: Direct heterozygous sheep growth comparison.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: Ovine p.Val700Glu is distinct from the human alleles; no human hearing phenotype is inferred. Greater frame size did not imply higher body weight or longissimus muscle area at a given age.
    fidelity: MODERATE
  evidence:
  - reference: PMID:16441300
    reference_title: A single-base change in the tyrosine kinase II domain of ovine FGFR3 causes hereditary chondrodysplasia in sheep.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the mutant FGFR3 allele has an additive effect on long-bone length
    explanation: Primary ovine genetic study, replacing secondary citation through the human report.
  - reference: PMID:17032787
    reference_title: Enhanced skeletal growth of sheep heterozygous for an inactivated fibroblast growth factor receptor 3.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: At maturity, FGFR3(SLS/+) ewes exhibited a larger frame size and longer bones than normal FGFR3(+/+) ewes
    explanation: Direct heterozygous sheep growth comparison.
diagnosis:
- name: FGFR3 sequencing
  description: >-
    Phenotype-directed FGFR3 sequencing or broader sequencing can identify relevant kinase-domain variants, followed by segregation and variant interpretation. The founding family used linkage plus direct sequencing, the Thr546Lys brothers exome sequencing, and the Arg621Cys family targeted exon sequencing. A candidate case in a hearing-loss cohort was missed by a panel that omitted FGFR3 and detected by exome sequencing; a molecular finding alone does not establish pathogenicity.
  evidence:
  - reference: PMID:24864036
    reference_title: "A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Whole exome sequencing revealed a homozygous novel missense mutation in the FGFR3 gene in exon 12"
    explanation: Documents molecular confirmation as the diagnostic route.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: exon 14 and flanking exons of FGFR3 gene sequencing was performed.
    explanation: Cannova et al. document targeted sequencing rather than a linkage study in the Italian family.
- name: Audiometry with otoacoustic emissions
  description: >-
    Audiometry and otoacoustic emissions characterize the hearing phenotype. The Utah family had bilateral sensorineural loss and absent emissions in tested individuals. Follow-up is relevant because childhood onset and variable progression occur; normal CT/MRI does not exclude a cochlear cellular lesion.
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "On audiological exam, each tested individual had bilateral sensorineural hearing loss and absent otoacoustic emissions"
    explanation: Describes the audiological findings that define the test result.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
differential_diagnoses:
- name: Marfan syndrome
  disease_term:
    preferred_term: Marfan syndrome
    term:
      id: MONDO:0007947
      label: Marfan syndrome
  description: >-
    The obvious alternative for tall stature with arachnodactyly and scoliosis,
    and the one the original investigators formally excluded.
  distinguishing_features:
  - The examined Utah relatives lacked severe myopia, lens dislocation and aortic-root abnormalities, which argued against Marfan syndrome in that pedigree.
  - The combination of digital contractures and sensorineural hearing loss supports consideration of CATSHL; cardiac or ocular findings in an individual still require independent assessment.
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Marfan syndrome was considered a possible diagnosis, but no affected individuals who were examined had severe myopia, lens dislocation, or aortic-root abnormalities."
    explanation: Records the exclusion and the features used to make it.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: Hunter-MacDonald syndrome
  description: >-
    Shares camptodactyly, scoliosis and reduced hearing acuity, so it overlaps
    CATSHL on three of its four named features. Stature is the discriminator and
    it runs the opposite way.
  distinguishing_features:
  - Short stature rather than tall stature.
  - Epiphyseal dysplasia with early osteoarthritis, and a predisposition to meningioma.
  evidence:
  - reference: PMID:17972300
    reference_title: "The Hunter-MacDonald syndrome with expanded phenotype including risk of meningioma: an update and review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The skeletal manifestations of HMS include short stature, scoliosis, epiphyseal dysplasia with early osteoarthritis leading to joint replacement, prominent humeral insertions for the deltoids, camptodactyly, subluxation of the thumbs, and malformed feet."
    explanation: Lists the overlapping features together with the short stature that separates it from CATSHL.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: LADD syndrome
  description: >-
    Another FGFR3-related condition. Relevant because peg-shaped incisors, a
    LADD feature, turned up in one CATSHL proband, so the dental finding does not
    separate the two as cleanly as it appears to.
  distinguishing_features:
  - Lacrimal and salivary duct aplasia, hypoplasia or atresia are characteristic of LADD. Hearing, digital, dental and renal findings can overlap.
  - Tall stature and scoliosis favor the reported CATSHL pattern, but peg-shaped incisors and renal dysplasia in the Arg621Cys proband blur the clinical boundary.
  evidence:
  - reference: PMID:37990933
    reference_title: "CATSHL syndrome, a new family and phenotypic expansion."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The FGFR3 p.Arg621Cys variant seems to be a newly identified cause of CATSHL syndrome with some phenotypic overlap with the LADD syndrome."
    explanation: States the overlap the authors themselves drew between the two FGFR3 conditions.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: is characterized by aplasia, hypoplasia or atresia of the lacrimal and salivary ducts
    explanation: Cannova et al. review the differentiating duct abnormalities and shared findings.
treatments:
- name: Hearing Amplification
  description: >-
    Audiological evaluation and hearing amplification are supportive management options for sensorineural loss. FGFR3 clinical-care resources recommend early recognition and treatment of hearing impairment, but the cited sources do not provide CATSHL-specific hearing-aid outcome estimates.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: Hearing rehabilitation with amplification
    term:
      id: NCIT:C15315
      label: Rehabilitation
  target_phenotypes:
  - preferred_term: Bilateral sensorineural hearing impairment
    term:
      id: HP:0008619
      label: Bilateral sensorineural hearing impairment
    description: Symptomatic target
  evidence:
  - reference: url:https://research.nhgri.nih.gov/CGD/view/?g=FGFR3
    reference_title: Clinical Genomic Database
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
    explanation: NHGRI clinical-care summary for the FGFR3 group including CATSHL; management rationale, not a CATSHL treatment trial.
  - reference: PMID:35793999
    reference_title: Clinical management and emerging therapies of FGFR3-related skeletal dysplasia in childhood.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Other treatment interventions may include antiseizure medications, hearing aids, and individualized developmental support.
    explanation: General FGFR3 skeletal-dysplasia supportive care; only hearing aids are used to support this intervention.
- name: Scoliosis Surgery
  description: >-
    Spinal surgery was performed at age 23 for scoliosis in the Italian Arg621Cys father. The case establishes use, not comparative effectiveness or a standardized CATSHL surgical protocol.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: orthopedic surgical procedure
    term:
      id: NCIT:C16186
      label: Orthopedic Surgical Procedure
  target_phenotypes:
  - preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
    description: Symptomatic target
  evidence:
  - reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    reference_title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: He had thoracic scoliosis that required spinal surgery at the age of 23.
    explanation: Cannova et al. document surgery in the affected father.
- name: Genetic Counseling
  description: >-
    Counseling depends on the allele, parental genotype and uncertain penetrance. A heterozygous dominant-associated allele has a 50% transmission probability per pregnancy; if both parents carry the same recessive-associated allele, each pregnancy has a 25% probability of homozygosity. These are conditional genotype probabilities, not guarantees of phenotype or severity. Subtle heterozygous manifestations and the Moderate gene-disease validity assessment should inform interpretation.
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d
    reference_title: curation results for Gene-Disease Validity
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Mother and father are mildly affected with slight tall stature, relative microcephaly, and long lower limbs.
    explanation: ClinGen family abstraction supports counseling that heterozygous phenotype need not be completely absent. The Mendelian genotype probabilities are conditional inferences.
- name: Developmental Support
  description: Individualized developmental support is a general supportive-care option when delay or learning difficulties are present; no CATSHL-specific efficacy study is reported in the cited review.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Rehabilitation
    term:
      id: NCIT:C15315
      label: Rehabilitation
  target_phenotypes:
  - preferred_term: Neurodevelopmental delay
    term:
      id: HP:0012758
      label: Neurodevelopmental delay
    description: Symptomatic target
  - preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
    description: Symptomatic target
  evidence:
  - reference: PMID:35793999
    reference_title: Clinical management and emerging therapies of FGFR3-related skeletal dysplasia in childhood.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
    snippet: Other treatment interventions may include antiseizure medications, hearing aids, and individualized developmental support.
    explanation: General FGFR3-disorder review supports individualized developmental care, not a disease-specific effect estimate.
- name: Experimental Hedgehog Inhibition
  description: Vismodegib prevented chondroma-like lesions in conditional Fgfr3-deficient mice during a four-week treatment window. The same intervention induced premature growth-plate fusion and reduced long-bone length in controls and mutants. This is a preclinical pathway experiment with important developmental toxicity, not demonstrated CATSHL treatment.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: Vismodegib
      term:
        id: NCIT:C74038
        label: Vismodegib
  target_mechanisms:
  - target: Derepressed Indian Hedgehog Signaling
    treatment_effect: INHIBITS
    description: Smoothened inhibition reduces Hedgehog signaling in the mouse experiment.
  evidence:
  - reference: PMID:26091072
    reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: there were no chondroma-like lesions in the mutants after 4 weeks of SMOi treatment
    explanation: Mouse lesion prevention with GDC-0449/vismodegib.
  - reference: PMID:26091072
    reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: adverse secondary effects were induced, including premature growth plate fusion leading to a shorter long bone
    explanation: Developmental toxicity limits therapeutic interpretation.
- name: Experimental Wnt Inhibition
  description: XAV939 exposure at 2.5 micromolar from 10–20 days post fertilization partly improved cranial/cartilage abnormalities in fgfr3-mutant zebrafish. Delayed intramembranous ossification was not significantly corrected. This is a preclinical partial rescue and does not establish human efficacy or safety.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: XAV939
      term:
        id: CHEBI:62878
        label: XAV939
  target_mechanisms:
  - target: Enhanced Canonical Wnt Signaling
    treatment_effect: INHIBITS
    description: XAV939 promotes beta-catenin degradation through axin stabilization in the fish experiment.
  evidence:
  - reference: PMID:32641982
    reference_title: Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: The abnormal arrangement and hypertrophy of chondrocytes in ceratohyal cartilage were both alleviated in XAV939-treated mutants.
    explanation: Partial cartilage rescue.
  - reference: PMID:32641982
    reference_title: Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: the delayed intramembranous ossification of opercle and branchiostegal rays was not significantly changed in XAV939-treated mutants
    explanation: No significant rescue of the distinct intramembranous-ossification readout.
discussions:
- discussion_id: catshl_craniofacial_model_mismatch
  kind: HUMAN_MODEL_MISMATCH
  prompt: >-
    Which cranial developmental mechanisms explain human CATSHL findings, and how well do the mouse and zebrafish models capture them?
  rationale: >-
    The 2020 study reports that the then-characterized Fgfr3-deficient mouse models lacked an apparent craniofacial skeletal phenotype, while its zebrafish model had cranial malformation and delayed sutural closure. Fish cartilage and osteoblast readouts support distinct developmental contributions, and Wnt inhibition partly improved cartilage but not intramembranous ossification. These findings do not establish the basis of human intellectual disability or prove that every mouse model lacks every cranial abnormality. Relative microcephaly in a very tall individual must also be distinguished from absolute microcephaly.
  attaches_to:
  - phenotypes#Microcephaly
  - phenotypes#High Palate
  - phenotypes#Wormian Bones
  - phenotypes#Intellectual Disability
  - pathophysiology#Delayed Cranial Ossification
  evidence:
  - reference: PMID:32641982
    reference_title: "Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "The reason for the discrepant in the craniofacial phenotypes between mouse model and patients remains to be studied."
    explanation: >-
      The authors state the mismatch explicitly and record it as unresolved.
      Quoted as written, including the grammatical slip in the original.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:32641982
    reference_title: "Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "craniofacial bone malformation with microcephaly and delayed closure of cranial sutures"
    explanation: Establishes that the zebrafish, unlike the mouse, does show the craniofacial phenotype.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- discussion_id: catshl_dominant_negative_untested
  kind: KNOWLEDGE_GAP
  prompt: >-
    Do the Arg621 alleles act as dominant negatives, and if so does the mutant
    receptor actually inhibit its wild-type partner?
  rationale: >-
    The original Arg621His report inferred a dominant-negative mechanism from structural modeling, expression/localization observations and comparisons with null genotypes. It did not demonstrate mutant/wild-type heterodimer inhibition. ClinGen retains this as a proposed mechanism. Direct measurements of variant-specific kinase activity and signaling in relevant tissues are needed to distinguish hypomorphic, dominant-negative and context-dependent effects, including for the later candidate alleles.
  attaches_to:
  - pathophysiology#FGFR3 Kinase-Domain Loss of Function
  evidence:
  - reference: PMID:17033969
    reference_title: "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "For several reasons, it is unlikely that the loss of function caused by p.R621H results from haploinsufficiency."
    explanation: The authors' own framing of the mechanism as an inference from exclusion rather than a demonstration.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- discussion_id: catshl_bidirectional_cochlear_failure
  kind: KNOWLEDGE_GAP
  prompt: >-
    Why does either too little or too much FGFR3 signaling cause deafness?
  rationale: >-
    Loss of Fgfr3 abolishes pillar cell differentiation; the activating Y367C
    allele produces fully penetrant deafness with an increased number of pillar
    or modified supporting cells. The organ of Corti therefore fails in both
    directions from an intermediate optimum, which is unusual and is not
    explained by a simple dose-response model of the receptor. Whether the two
    deafnesses share a final common lesion or are distinct failures of the same
    patterning step is unknown, and the answer would constrain how the human
    hearing loss is expected to progress.
  attaches_to:
  - pathophysiology#Failure of Cochlear Pillar Cell Differentiation
  evidence:
  - reference: PMID:19073250
    reference_title: "Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "The inner ear defect is mainly associated with an increased number of pillar cells or modified supporting cells in the organ of Corti."
    explanation: >-
      Shows the gain-of-function receptor producing the opposite cellular change
      in the same structure, which is what makes the bidirectional failure a real
      question rather than a rhetorical one.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:19073250
    reference_title: "Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "The mutant Fgfr3(Y367C/+) mice exhibit fully penetrant deafness with a significantly elevated auditory brainstem response threshold for all frequencies tested."
    explanation: Establishes that the activating allele also causes deafness, not merely a cellular change.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
references:
- reference: PMID:16441300
  title: A single-base change in the tyrosine kinase II domain of ovine FGFR3 causes hereditary chondrodysplasia in sheep.
- reference: PMID:17032787
  title: Enhanced skeletal growth of sheep heterozygous for an inactivated fibroblast growth factor receptor 3.
- reference: PMID:17033969
  title: A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.
- reference: PMID:17117437
  title: Loss of Fgfr3 leads to excess hair cell development in the mouse organ of Corti.
- reference: PMID:17972300
  title: "The Hunter-MacDonald syndrome with expanded phenotype including risk of meningioma: an update and review."
- reference: PMID:19073250
  title: "Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia."
- reference: PMID:24864036
  title: "A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly."
- reference: PMID:26091072
  title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
- reference: PMID:27139183
  title: 'A second family with CATSHL syndrome: Confirmatory report of another unique FGFR3 syndrome.'
- reference: PMID:32641982
  title: "Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling."
- reference: PMID:35793999
  title: Clinical management and emerging therapies of FGFR3-related skeletal dysplasia in childhood.
- reference: PMID:37990933
  title: "CATSHL syndrome, a new family and phenotypic expansion."
- reference: PMID:38307035
  title: "Genetic Testing of Children With Familial Tall Stature: Is it Worth Doing?"
- reference: PMID:39498320
  title: 'Genetic heterogeneity in autosomal recessive hearing loss: a survey of Brazilian families.'
- reference: PMID:8601314
  title: Fibroblast growth factor receptor 3 is a negative regulator of bone growth.
- reference: PMID:8630492
  title: "Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3."
- reference: url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
  title: https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf
- reference: url:https://research.nhgri.nih.gov/CGD/view/?g=FGFR3
  title: Clinical Genomic Database
- reference: url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d
  title: curation results for Gene-Disease Validity
notes: >-
  FGFR3-CATSHL gene-disease validity is Moderate in the August 2026 ClinGen reevaluation. Classic families, candidate tall-stature variants and the average-stature Asn540Asp hearing-loss case have different levels of phenotypic and variant support. Human frequencies derive from small ascertained pedigrees.

  Neurodevelopmental findings, digital contractures, chest-wall deformity and the additional renal, dental and minor dysmorphic observations do not yet have experimentally established causal routes; their presence is recorded without assigning them to the cartilage or cochlear pathway by default. Relative microcephaly in the Italian proband is not coded as absolute microcephaly.

  Experimental Hedgehog and Wnt interventions are model-system results, not demonstrated CATSHL therapies. Achondroplasia-directed FGFR3/MAPK inhibition cannot be assumed appropriate for an impaired-signaling disorder. The activating Y367C mouse informs the bidirectional cochlear discussion and is not a CATSHL model. The Cannova full-text PDF cache retains its fetcher-generated URL title; the article identity is PMID:37990933, DOI:10.1111/cge.14455.
experimental_models:
- name: Fgfr3-deficient primary mouse chondrocytes
  experimental_model_type: PRIMARY_CELL_CULTURE
  cell_source: Knee-joint cartilage from three-day-old mice; deletion induced with 4-hydroxytamoxifen in culture
  publication: PMID:26091072
  description: Primary chondrocytes test FGF18-induced ERK activity, Ihh/Pthrp expression and pathway inhibition. Basal apoptosis in isolated mutant cells did not reproduce the decrease observed in the hypertrophic zone in vivo.
  modeled_mechanisms:
  - target: Reduced MAPK/ERK Output in Growth Plate Chondrocytes
    description: FGF18-induced ERK activation is reduced.
    evidence:
    - reference: PMID:26091072
      reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: MAPK activation in response to FGF18 was also reduced in Fgfr3-deficient chondrocytes
      explanation: Primary-cell signaling assay.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: MOLECULAR
    limitations: Neonatal cultured cells are not patient growth-plate tissue.
    fidelity: MODERATE
  - target: Derepressed Indian Hedgehog Signaling
    description: Ihh/Pthrp expression rises after receptor deletion or MEK inhibition.
    evidence:
    - reference: PMID:26091072
      reference_title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
      supports: SUPPORT
      evidence_source: IN_VITRO
      quote_role: PRIMARY_RESULT
      directness: DIRECT
      snippet: Ihh and Pthrp mRNA levels were increased in Fgfr3-deficient chondrocytes
      explanation: Primary-cell gene-expression result.
    relationship: PARTIALLY_RECAPITULATES
    model_scale: MOLECULAR
    limitations: Does not establish all downstream steps in patients.
    fidelity: MODERATE
- name: Arg621His patient fibroblast expression observations
  experimental_model_type: PRIMARY_CELL_CULTURE
  cell_source: Fibroblasts from affected members of the founding pedigree
  publication: PMID:17033969
  description: Patient fibroblasts expressed both mutant and wild-type transcripts, and receptor localization was described as normal. These observations inform proposed mechanisms but do not measure receptor kinase inhibition or functional rescue.
  modeled_mechanisms: []
  evidence:
  - reference: PMID:17033969
    reference_title: A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    quote_role: PRIMARY_RESULT
    directness: DIRECT
    snippet: express both wild-type and mutant (i.e., p.R621H-containing)FGFR3RNA in nearly equal proportions
    explanation: Patient-cell expression result; the report states that related localization data were not shown.
  notes: No kinase-activity or rescue link is assigned to these expression/localization observations.
computational_models:
- name: Arg621His kinase-domain homology model
  model_type: STRUCTURAL_PREDICTION
  publication: PMID:17033969
  description: The FGFR1 kinase crystal structure was used to infer the catalytic-loop role of the homologous FGFR3 Arg621 residue and model a histidine side chain.
  modeled_mechanisms:
  - target: FGFR3 Kinase-Domain Loss of Function
    description: Structural modeling predicts interference with phosphate transfer.
    evidence:
    - reference: PMID:17033969
      reference_title: A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
      snippet: The p.R621H substitution may therefore interfere with the ability of FGFR3 to transfer phosphate to its peptide substrate, resulting in loss of function
      explanation: Structural prediction, not an enzymatic assay.
    relationship: PERTURBS
    model_scale: MOLECULAR
    limitations: Uses a homologous receptor structure and does not demonstrate mutant/wild-type dimer inhibition.
    fidelity: LOW

📚

References & Deep Research

References

19

PMID:16441300

A single-base change in the tyrosine kinase II domain of ovine FGFR3 causes hereditary chondrodysplasia in sheep.

No top-level findings curated for this source.

PMID:17032787

Enhanced skeletal growth of sheep heterozygous for an inactivated fibroblast growth factor receptor 3.

No top-level findings curated for this source.

PMID:17033969

A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.

No top-level findings curated for this source.

PMID:17117437

Loss of Fgfr3 leads to excess hair cell development in the mouse organ of Corti.

No top-level findings curated for this source.

PMID:17972300

The Hunter-MacDonald syndrome with expanded phenotype including risk of meningioma: an update and review.

No top-level findings curated for this source.

PMID:19073250

Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia.

No top-level findings curated for this source.

PMID:24864036

A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly.

No top-level findings curated for this source.

PMID:26091072

FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.

No top-level findings curated for this source.

PMID:27139183

A second family with CATSHL syndrome: Confirmatory report of another unique FGFR3 syndrome.

No top-level findings curated for this source.

PMID:32641982

Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.

No top-level findings curated for this source.

PMID:35793999

Clinical management and emerging therapies of FGFR3-related skeletal dysplasia in childhood.

No top-level findings curated for this source.

PMID:37990933

CATSHL syndrome, a new family and phenotypic expansion.

No top-level findings curated for this source.

PMID:38307035

Genetic Testing of Children With Familial Tall Stature: Is it Worth Doing?

No top-level findings curated for this source.

PMID:39498320

Genetic heterogeneity in autosomal recessive hearing loss: a survey of Brazilian families.

No top-level findings curated for this source.

PMID:8601314

Fibroblast growth factor receptor 3 is a negative regulator of bone growth.

No top-level findings curated for this source.

PMID:8630492

Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.

No top-level findings curated for this source.

url:https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf

https://air.unimi.it/retrieve/627c309a-8b19-4de3-aaee-33b598f0e8c2/Clinical%20Genetics%20-%202023%20-%20Cannova%20-%20CATSHL%20syndrome%20a%20new%20family%20and%20phenotypic%20expansion.pdf

No top-level findings curated for this source.

url:https://research.nhgri.nih.gov/CGD/view/?g=FGFR3

Clinical Genomic Database

No top-level findings curated for this source.

url:https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_90130560-3e24-46a9-beaa-c67792773d3d

curation results for Gene-Disease Validity

No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (3)

Re-curate: CATSHL Syndrome · 2026-10-14T05:58:18Z · View source

Re-curation audit of an already extensive entry. Inheritance (AD Arg621His/Arg621Cys; AR homozygous Thr546Lys with subtly affected heterozygous parents), all published families, mechanism nodes, animal models and the ClinGen Moderate validity assertion were checked and left as curated. Changes: (1) wired the Endochondral Bone and Vertebral Overgrowth node to Tibial Bowing, and gave its Scoliosis edge evidence, both from the Fgfr3-null mouse report of long-bone curvature, kyphosis and scoliosis (PMID:8630492), graded INDIRECT because the human deformities are linked by analogy; (2) added a Tibial Bowing -> Loss of Ambulation sequela and primary evidence for the tibial deformity from the homozygous Thr546Lys report (PMID:24864036), which previously rested only on the ClinGen abstraction; (3) cited the primary familial tall stature study (PMID:38307035) behind the Ala514Asp and Asn653Lys records, graded INDIRECT because its abstract neither names the allele nor reports the CATSHL triad. Remaining disconnected phenotypes (camptodactyly, chest-wall, neurodevelopmental, dental, renal and minor dysmorphic findings) were left unconnected because no source establishes a mechanism for them. New deep research could not be obtained: Falcon failed on provider authentication and Perplexity disconnected twice without a response, so the existing claude_code report and direct PubMed searches were the literature basis.

Review CATSHL human evidence and model-specific mechanisms · 2026-10-01T18:38:38Z · View source

Reviewed the complete entry, prior history, matching deep-research report and cached literature, including full primary texts for the founding family, Italian phenotype expansion, mouse cartilage experiments, zebrafish study and Brazilian candidate case. Added the omitted 2016 family and current 2026 ClinGen Moderate assessment; qualified additional candidate alleles and parental manifestations. Corrected pedigree-based frequencies, combined developmental-delay/intellectual-disability counts, hearing onset and inferred human mechanisms. Expanded phenotypes, separated cellular mechanisms, and added primary-cell/structural models plus experimentally bounded Hedgehog/Wnt interventions. All 121 quotations and 139 titles validate. No dedicated GeneReviews chapter or CATSHL trial was found in the available chapter census and current registry search.

Create: CATSHL Syndrome · 2026-08-29T19:55:46Z · View source

Created kb/disorders/CATSHL_Syndrome.yaml for camptodactyly-tall stature-scoliosis-hearing loss syndrome, MONDO:0012504. Deep research run with the claude_code provider; the report passed preflight-dr against MONDO:0012504 with FGFR3 mentioned 44 times and matching OMIM 610474. Reference validation of the report flagged one unresolved identifier, a markdown-mangled DOI for the PLOS Genetics chondroma paper; the underlying DOI 10.1371/journal.pgen.1005214 was resolved independently through the PMC ID converter to PMID:26091072 and that PMID was cited instead. Term validation of the report flagged four CURIEs the ontology names as something else entirely, CL:0002261, UBERON:0002391, UBERON:0004674 and UBERON:0002228; none was bound, and the correct terms were looked up directly through OLS. Six references cited, all cached; 58 of 58 snippets verified against the cache. Modelled as an FGFR3 loss-of-function chain with a skeletal arm and a separate cochlear arm branching at the receptor, four animal models including the naturally occurring ovine spider lamb syndrome, and three discussions covering the mouse craniofacial mismatch, the untested dominant-negative mechanism and the bidirectional cochlear failure. No conforms_to against the FGFR gain-of-function module, which is scoped to activating alleles; the reasoning is recorded in notes.

Claude Code ▸

CATSHL Syndrome (Camptodactyly, Tall Stature, and Hearing Loss Syndrome): Comprehensive Research Report

claude-haiku-4-5-20251001, claude-sonnet-5 13 citations 2026-08-29T19:40:46.123339

CATSHL Syndrome (Camptodactyly, Tall Stature, and Hearing Loss Syndrome): Comprehensive Research Report

1. Disease Information

Overview. CATSHL syndrome — an acronym for CAmptodactyly, Tall Stature, and Hearing Loss — is an ultra-rare skeletal dysplasia/overgrowth syndrome caused by loss-of-function variants in the FGFR3 (fibroblast growth factor receptor 3) gene. It is notable as essentially the phenotypic mirror image of achondroplasia: whereas achondroplasia results from gain-of-function FGFR3 mutations that cause short stature, CATSHL results from loss-of-function FGFR3 mutations that cause tall stature, alongside camptodactyly, scoliosis/chest-wall anomalies, and congenital or early-onset sensorineural hearing loss Toydemir et al., 2006, Am J Hum Genet 79(5):935-941, PMID:17033969.

Key identifiers: - OMIM: #610474 (CATSHLS — CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME) — gene locus FGFR3 (134934) OMIM 610474 - Orphanet: ORPHA:85164 — "Camptodactyly-tall stature-scoliosis-hearing loss syndrome" Orphanet 85164 - MONDO: MONDO:0012504 - Disease Ontology: DOID:0111160 - MedGen/UMLS Concept: C1864852 NCBI MedGen 355844 - Gene:* FGFR3, chromosome 4p16.3; HGNC gene ID for the causal gene

Synonyms: CATSHL syndrome; Camptodactyly–tall stature–hearing loss syndrome; Camptodactyly–tall stature–scoliosis–hearing loss syndrome.

Data provenance. Nearly all published knowledge of CATSHL derives from a small number of aggregated pedigree/case reports in the peer-reviewed literature (not large-scale EHR or registry data), supplemented by animal-model studies (mouse and zebrafish Fgfr3 loss-of-function models) that established the underlying mechanism before and alongside the human descriptions.

2. Etiology

Primary cause — genetic (monogenic). CATSHL is caused by heterozygous (autosomal dominant) or, more rarely, homozygous (autosomal recessive) missense loss-of-function mutations in FGFR3, the gene encoding a receptor tyrosine kinase that normally acts as a negative regulator of bone growth in the cartilage growth plate Colvin et al., 1996, Nat Genet 12:390-397, PMID:8630492; Deng et al., 1996, Cell, PMID:8601314.

Genetic risk factors / causal variants identified to date:

Variant (protein)	cDNA change	Zygosity/Inheritance	Family	Reference
p.Arg621His (R621H)	c.1862G>A	Heterozygous, autosomal dominant	27 living affected of a 4-generation (7-generation historically) Utah pedigree (~35 affected total)	Toydemir et al. 2006, PMID:17033969
p.Thr546Lys (T546K)	c.1637C>A	Homozygous, autosomal recessive (consanguineous parents); heterozygous carriers unaffected	2 brothers, consanguineous Egyptian family	Makrythanasis et al. 2014, Hum Mutat 35:959-963
p.Arg621Cys (R621C)	c.1861C>T	Heterozygous, autosomal dominant (novel, same residue as R621H but different substitution)	Father and 12-year-old daughter, Italian family (new 2024 report)	Cannova et al. 2024, Clin Genet 105:313-316, PMID:37990933

All are located in/near the tyrosine kinase domain of FGFR3 and are functionally characterized as reducing (R621H, partial loss) or abolishing receptor kinase activity, in contrast to the gain-of-function substitutions (e.g., G380R, K650E) that cause achondroplasia/thanatophoric dysplasia at other FGFR3 residues.

Environmental/lifestyle risk factors: None identified — CATSHL is a purely monogenic condition; no environmental, infectious, or lifestyle contributors have been reported.

Protective factors: None specifically documented. No modifier genes or protective alleles are reported in the literature to date.

Gene-environment interaction: Not applicable/not studied — this is a fully penetrant single-gene disorder with no reported environmental modulation.

3. Phenotypes

Core tetrad

Camptodactyly — permanent, irreducible flexion of one or more fingers and/or toes (HPO: HP:0012385, Camptodactyly, or the more general HP:0002813, Abnormality of joint mobility)
Tall stature — postnatal-onset overgrowth, disproportionate to family background (HPO: HP:0000098, Tall stature)
Scoliosis / chest-wall anomalies — scoliosis and/or pectus excavatum (HPO: HP:0002650 Scoliosis; HP:0000767 Pectus excavatum)
Sensorineural hearing loss — bilateral, with absent otoacoustic emissions, congenital or early-infancy onset, variably progressive, ranging mild–severe (HPO: HP:0000407, Sensorineural hearing impairment; HP:0008625, Bilateral sensorineural hearing impairment)

Additional reported phenotypes

Microcephaly in a subset of patients (HPO: HP:0000252)
Developmental delay / intellectual disability — reported in some patients, notably the more severely affected Egyptian brother (IQ ~70) in the homozygous T546K family (HPO: HP:0001263 Developmental delay; HP:0001249 Intellectual disability)
Severe lateral tibial deviation, arachnodactyly, and inability to ambulate in the severe homozygous (recessive) presentation (Makrythanasis et al. 2014)
Peg-shaped incisors — newly described in the 2024 Italian family with p.Arg621Cys, a feature overlapping with LADD (Lacrimo-Auriculo-Dento-Digital) syndrome, another FGFR3-spectrum condition — representing a phenotypic expansion of CATSHL Cannova et al. 2024, PMID:37990933
Lower-limb joint abnormalities

Phenotype characteristics

Onset: Tall stature typically becomes apparent postnatally/in childhood; hearing loss is congenital or manifests in early infancy; camptodactyly is present from early life.
Severity/course: Hearing loss is variably progressive in early childhood; overall severity is markedly worse in the homozygous/biallelic (recessive) form (inability to walk, more pronounced skeletal deformity, intellectual disability) than in the heterozygous dominant form.
Frequency among affected individuals: Camptodactyly, tall stature, and hearing loss are present in essentially all reported/genetically confirmed cases (definitional); scoliosis/pectus excavatum, microcephaly, and intellectual disability are variable/less penetrant secondary features.
Quality of life impact: Not formally studied with standardized instruments (no EQ-5D/SF-36 data identified); clinically, hearing loss and orthopedic/mobility impairment (particularly in the recessive form) are the primary functional burdens.

4. Genetic/Molecular Information

Causal gene: FGFR3 (Fibroblast Growth Factor Receptor 3), HGNC gene, OMIM 134934, chromosome 4p16.3*.
Variant classification: All reported CATSHL variants are missense, classified as pathogenic/likely pathogenic loss-of-function or partial-loss-of-function alleles (ACMG/AMP framework); ClinVar entries exist for c.1637C>A (p.Thr546Lys) ClinVar RCV000144699 and for the R621H/R621C tyrosine-kinase-domain substitutions.
Variant type: All missense substitutions clustered in or near the tyrosine kinase domain — distinct from the extracellular Ig-like/transmembrane domain hotspots (e.g., G380R) that cause the gain-of-function achondroplasia spectrum.
Somatic vs. germline: All reported CATSHL variants are germline; no somatic CATSHL cases reported (unlike some FGFR3 gain-of-function conditions, which can also arise somatically in certain skin/bladder neoplasms — not relevant here).
Functional consequence: Loss of function / partial loss of function of FGFR3 kinase activity. Because FGFR3 is normally an inhibitory (negative) regulator of chondrocyte proliferation/differentiation and bone growth, its functional inactivation derepresses growth-plate chondrogenesis, producing skeletal overgrowth — the inverse of achondroplasia's growth suppression from constitutive receptor activation. The dominant R621H allele behaves as a partial loss-of-function/possible dominant-negative allele sufficient to cause disease in the heterozygous state, whereas T546K requires biallelic (homozygous) loss for full clinical expression — heterozygous T546K carriers (parents, unaffected sister) are clinically unaffected, indicating a milder functional deficit per allele than R621H.
Allele frequency: These are private, rare familial variants; not appreciable in population databases such as gnomAD (consistent with disease-causing rarity).
Modifier genes: None established; the recessive vs. dominant difference between T546K and R621H appears to reflect differing residual kinase activity of each specific substitution rather than a separate modifier locus.
Epigenetics/chromosomal abnormalities: None reported — CATSHL is caused by point mutations, not by copy-number, translocation, or epigenetic mechanisms.

5. Environmental Information

No environmental, infectious, occupational, or lifestyle contributing factors have been identified or hypothesized for CATSHL syndrome in the literature; it is presented uniformly as a monogenic Mendelian condition with full genetic causation.

6. Mechanism / Pathophysiology

Molecular pathway and causal chain

FGFR3 is a receptor tyrosine kinase highly expressed in the proliferative and prehypertrophic zones of the cartilage growth plate, as well as in the cochlea, brain, and spinal cord. In the growth plate, ligand-activated FGFR3 signals principally through the MAPK/ERK cascade (and secondarily PI3K/AKT, PKCγ, and STAT1) to inhibit chondrocyte proliferation and hypertrophic differentiation, thereby restraining endochondral bone elongation — i.e., FGFR3 is physiologically a negative regulator of bone growth Colvin et al. 1996, PMID:8630492; Deng et al. 1996, Cell, PMID:8601314.

In achondroplasia/thanatophoric dysplasia, gain-of-function FGFR3 mutations hyperactivate this inhibitory MAPK signal → excess growth suppression → short-limbed dwarfism.
In CATSHL, loss-of-function FGFR3 mutations reduce MAPK-mediated inhibition of chondrocyte proliferation/hypertrophy → disinhibited endochondral growth → tall stature and long-bone/vertebral overgrowth. Conditional chondrocyte-specific Fgfr3 knockout mice show markedly lengthened growth plates, increased osteoblast number, and increased bone formation and bone mass.
Postnatal Fgfr3 deletion in chondrocytes also produces chondroma-like lesions (enchondromas/osteochondromas) adjacent to disordered growth plates, associated with decreased ERK activity and upregulated Indian hedgehog (IHH) signaling; pharmacologic IHH-pathway inhibition reduced lesion occurrence in Fgfr3-deficient mice, implicating derepressed Hedgehog signaling as a downstream driver of the skeletal dysplasia phenotype Zhou et al. 2015, PLOS Genetics, PMID (Zhou/Wen/Chen et al.); doi:10.1371/journal.pgen.1005214.
A zebrafish CRISPR/Cas9 fgfr3 loss-of-function model (frameshift mutations in the tyrosine-kinase domain) recapitulated microcephaly, craniofacial dysmorphism (domed skull, mandibular deformity), delayed endochondral and intramembranous ossification, chondroma-like growth-plate lesions, and abnormal chondrocyte hypertrophy — and demonstrated enhanced canonical Wnt/β-catenin signaling alongside increased IHH signaling as a partial molecular driver; pharmacologic Wnt/β-catenin inhibition (XAV939) partially rescued the chondrocyte/craniofacial phenotype, suggesting a therapeutic pathway target Sun X. et al. 2020, Theranostics 10(16):7111-7130, PMID:32641982.

Hearing loss mechanism

FGFR3 is expressed from approximately embryonic day 16 in the mouse cochlear duct in a domain that gives rise to pillar cells, outer hair cells, and Deiters' cells, and becomes restricted to pillar cells by birth. FGF8 signals from inner hair cells to FGFR3-expressing supporting cells to drive pillar-cell differentiation. Fgfr3-null mice show failure of pillar cell differentiation and failure of tunnel-of-Corti formation, with two rows of undifferentiated cells persisting in the pillar-cell region, altered pillar-cell innervation/fiber-guidance, and profound deafness — establishing FGFR3 loss-of-function as directly causal for the inner-ear phenotype, mirroring the human sensorineural hearing loss in CATSHL Colvin et al. 1996, PMID:8630492; Puligilla et al./Mueller et al., FGFR3 pillar cell studies, J Neurosci 22(21):9368; Hayashi et al. 2007, Dev Dyn, "Loss of Fgfr3 leads to excess hair cell development in the mouse organ of Corti". Downstream transcription factors Etv4/Etv5/Etv1 appear to act as key FGFR3-dependent regulators of pillar-cell identity. This contrasts with the reciprocal FGFR3 gain-of-function mouse model (activating Y367C mutation, modeling Muenke/achondroplasia-spectrum craniosynostosis), which also causes hearing loss but via excessive FGF signaling and altered pillar/Deiters cell ratios — indicating that both too little and too much FGFR3 signaling disrupt normal organ of Corti patterning [PMID:19073250].

Causal chain summary

FGFR3 loss-of-function variant (germline) → reduced receptor tyrosine kinase activity → diminished inhibitory MAPK/ERK signaling in growth-plate chondrocytes + derepressed IHH and Wnt/β-catenin signaling → disinhibited chondrocyte proliferation/hypertrophy and endochondral ossification → long-bone/vertebral overgrowth (tall stature), joint contractures (camptodactyly), spinal curvature (scoliosis); in parallel, loss of FGFR3-dependent FGF8 signal transduction in cochlear supporting cells → failure of pillar cell differentiation/tunnel of Corti formation → sensorineural hearing loss.

Suggested ontology terms

GO (biological process): GO:0007173 (epidermal growth factor receptor signaling pathway analog)/more precisely GO:0008543 (fibroblast growth factor receptor signaling pathway); GO:0060445 (branching involved in salivary gland morphogenesis – not relevant); relevant terms: GO:0060563 (Deiters' cell differentiation-adjacent), GO:0003417 (growth plate cartilage chondrocyte growth), GO:0061036 (positive regulation of cartilage development), GO:0021940 (positive regulation of cerebellar granule cell precursor proliferation – not relevant); most directly: GO:0008543 (fibroblast growth factor receptor signaling pathway), GO:0061181 (regulation of chondrocyte development), MAPK cascade GO:0000165.
GO (molecular function): GO:0005007 (fibroblast growth factor-activated receptor activity), GO:0004713 (protein tyrosine kinase activity)
GO (cellular component): GO:0005886 (plasma membrane), GO:0043235 (receptor complex)
CL (cell types): CL:0000138 (chondrocyte), CL:0000743 (hypertrophic chondrocyte), pillar cell (organ of Corti; CL term for inner/outer pillar cell), CL:0002261 (Deiters' cell / cochlear supporting cell), CL:0000062 (osteoblast)

7. Anatomical Structures Affected

Organ level: - Skeletal system: long bones (femur, tibia), vertebral column (scoliosis), phalanges/digits (camptodactyly), thoracic cage (pectus excavatum) — primary - Inner ear/cochlea: organ of Corti — primary - CNS: brain (microcephaly in a subset) — secondary - Body systems involved: musculoskeletal, auditory, and (variably) nervous system

Tissue/cell level: - Cartilage/growth plate — chondrocytes (proliferative and hypertrophic zones) — UBERON: growth plate cartilage - Bone — osteoblasts, endochondral and intramembranous ossification centers - Organ of Corti — pillar cells, Deiters' cells, outer hair cells, inner hair cells (Cell Ontology terms as above)

Subcellular level: FGFR3 is a plasma membrane receptor tyrosine kinase (GO:0005886); downstream effectors act in the cytoplasm (MAPK/ERK cascade components) and nucleus (transcriptional targets such as Etv4/5/1, and IHH/Wnt-β-catenin pathway effectors).

Localization/laterality: Skeletal overgrowth and camptodactyly are typically bilateral (may be asymmetric in digit involvement); hearing loss is bilateral sensorineural.

Relevant UBERON terms: UBERON:0002391 (cartilage of epiphysis / growth plate — approximate), UBERON:0001690 (ear), UBERON:0004674 (organ of Corti / spiral organ), UBERON:0002228 (rib cage / thoracic skeleton), UBERON:0002101 (limb).

8. Temporal Development

Onset: Congenital/early-infancy onset of hearing loss; tall stature emerges as a postnatal growth pattern typically evident in childhood; camptodactyly present from early life; scoliosis often develops/becomes apparent during growth (childhood/adolescence).
Onset pattern: Insidious/developmental rather than acute.
Progression: Hearing loss is described as variably progressive in early childhood, ranging from mild to severe by later assessment; skeletal overgrowth and scoliosis progress with growth and may stabilize post-puberty (as in other overgrowth syndromes), though formal longitudinal natural-history data are not established in the literature reviewed.
Disease course: Chronic, lifelong; no spontaneous remission reported. No mortality has been attributed to CATSHL in the literature to date — prognosis for survival is considered favorable.
Severity gradient over time: The recessive (homozygous T546K) presentation is more severe and disabling from an early age (loss of ambulation) than the dominant (heterozygous R621H/R621C) presentation.

9. Inheritance and Population

Inheritance pattern: Predominantly autosomal dominant (heterozygous R621H, R621C); rarely autosomal recessive (homozygous T546K in a consanguineous family, with unaffected heterozygous carrier parents/sibling) [Makrythanasis et al. 2014].
Penetrance: Appears high/complete for the dominant form within the reported Utah pedigree (affected individuals across 4–7 generations); the recessive T546K allele is essentially non-penetrant in the heterozygous state (unaffected carrier parents and sister), consistent with a true recessive, dosage-dependent mechanism.
Expressivity: Variable — severity (ambulation, intellectual disability, degree of hearing loss) differs between the dominant and recessive forms and even between siblings (e.g., the two Egyptian brothers differed in severity, with the older being unable to walk and having mild intellectual disability).
Genetic anticipation: Not reported.
Germline mosaicism: Not reported in the literature reviewed.
Founder effects/consanguinity: The recessive T546K case arose in a consanguineous Egyptian family, illustrating the classic mechanism by which a rare recessive allele can become homozygous; no broader founder-population data.
Carrier frequency: Not established (each identified variant is a private/family-specific finding, not present at appreciable frequency in population databases such as gnomAD).

Population demographics/epidemiology: - Extreme rarity: As of the most recent literature reviewed, approximately 30 documented individuals worldwide — the original 27 living affected members of the 4-generation (35 total across 7-generation) Utah pedigree [Toydemir et al. 2006], 2 brothers from a consanguineous Egyptian family [Makrythanasis et al. 2014], and most recently 2 additional affected individuals (father and daughter) from an Italian family with a novel variant [Cannova et al. 2024]. No formal population prevalence or incidence estimate exists (Orphanet lists it in the "not yet documented"/single-family-reported prevalence class). - Geographic distribution: Cases reported from the United States (Utah), Egypt, and Italy — no evidence of a specific endemic region; likely reflects ascertainment of individual pedigrees rather than a true geographic pattern. - Sex ratio: No skewed sex ratio reported (autosomal inheritance; both sexes affected in all reported families). - Age distribution: All age groups from childhood through adulthood represented across the reported pedigrees, consistent with a lifelong, non-lethal condition.

10. Diagnostics

Clinical recognition: Diagnosis is suspected clinically from the combination of postnatal-onset tall stature, camptodactyly, scoliosis/pectus excavatum, and bilateral sensorineural hearing loss with absent otoacoustic emissions, particularly in the setting of a compatible family history (autosomal dominant transmission across generations, or consanguinity for the recessive form).

Confirmatory genetic testing: - Single-gene FGFR3 sequencing (Sanger or targeted next-generation sequencing) of the tyrosine kinase domain exons is the definitive diagnostic test, as performed in all published cases (identification of R621H, T546K, R621C). - Gene panels for skeletal dysplasia/overgrowth or for syndromic hearing loss that include FGFR3 would be expected to capture CATSHL variants (per commercial genetic testing registries, e.g., NIH GTR listing for "Camptodactyly-tall stature-scoliosis-hearing loss syndrome," condition C1864852) NIH GTR. - Exome sequencing was the discovery method for the recessive T546K family (Makrythanasis et al. 2014), confirmed by Sanger sequencing and segregation analysis. - Audiometry/otoacoustic emissions testing to characterize and monitor the sensorineural hearing loss. - Skeletal radiographs to assess long-bone length, vertebral alignment (scoliosis), and joint contractures.

Differential diagnosis: Other overgrowth syndromes (e.g., Marfan syndrome, Sotos syndrome, homocystinuria) and other syndromic sensorineural hearing loss conditions should be considered; the co-occurrence of tall stature with hearing loss (rather than short stature, which characterizes the far more common FGFR3 gain-of-function conditions) is the key distinguishing clue toward FGFR3 loss-of-function/CATSHL. The 2024 Italian family report also highlights phenotypic overlap with LADD syndrome (another FGFR3-related condition) via a shared dental finding (peg-shaped incisors), underscoring the importance of molecular confirmation.

Screening: No population-based or newborn screening program exists for this ultra-rare condition; diagnosis relies on clinical suspicion and targeted/family-based genetic testing.

11. Outcome/Prognosis

Survival/mortality: No CATSHL-attributable deaths have been reported in the literature reviewed; life expectancy appears unaffected.
Morbidity: Primary functional morbidity relates to (a) sensorineural hearing loss (variable severity, potentially requiring amplification) and (b) orthopedic/mobility impact of severe skeletal deformity, most pronounced in the recessive (homozygous) form, where the more severely affected sibling was unable to walk.
Neurodevelopmental outcome: Developmental delay/intellectual disability is reported in a subset, more prominently associated with the recessive form (IQ ~70 in the more severely affected Egyptian brother) than clearly established for the dominant form.
Prognostic factors: Zygosity/allele appears to be the principal prognostic determinant identified to date — biallelic (homozygous) loss-of-function produces a substantially more severe phenotype than monoallelic (heterozygous) loss-of-function, consistent with a dosage-dependent mechanism.
Quality of life: Not formally quantified with standardized instruments in the literature reviewed.

12. Treatment

There is no disease-modifying or curative therapy for CATSHL syndrome; management is symptomatic and supportive, informed by general principles for the component features:

Hearing rehabilitation: Hearing aids for mild-to-severe sensorineural hearing loss with adequate speech discrimination; cochlear implantation would be a consideration for severe/profound loss, by analogy with management of other syndromic sensorineural hearing loss conditions, though CATSHL-specific implantation outcome data were not identified in the literature reviewed. (NCIT: NCIT:C15302 general rehabilitative care; hearing-aid fitting and cochlear implantation are standard-of-care interventions for sensorineural hearing loss broadly.)
Orthopedic management: Monitoring and, where indicated, surgical correction of scoliosis (NCIT:C15329, Surgical Procedure / orthopedic spinal surgery) and management of joint contractures/camptodactyly (splinting, physical therapy — NCIT:C15302, Physical Therapy) and severe lower-limb deformity (as in the recessive Egyptian family, where severe tibial deviation contributed to loss of ambulation).
Developmental/educational support: For patients with developmental delay/intellectual disability, standard early-intervention and educational support services.
Genetic counseling: Recommended given autosomal dominant (typically) or, less commonly, autosomal recessive inheritance, particularly relevant for consanguineous families (NCIT:C15240, Genetic Counseling).
Experimental/mechanistic leads (preclinical only): Animal-model studies suggest that pharmacologic modulation of downstream pathways disinhibited by FGFR3 loss — Hedgehog/IHH pathway inhibition (PLOS Genetics 2015 mouse study) and Wnt/β-catenin inhibition (XAV939) (zebrafish 2020 study) — can partially rescue chondrocyte/skeletal phenotypes in model systems, representing potential future therapeutic targets, but these have not been tested in human CATSHL patients and no clinical trials for CATSHL specifically were identified.

No NCT-registered clinical trials specific to CATSHL syndrome were identified in this research; existing FGFR3-targeted therapeutics in clinical development (e.g., FGFR3 inhibitors, CNP-pathway analogs such as vosoritide) are designed for the opposite (gain-of-function, achondroplasia-spectrum) mechanism and are not applicable to CATSHL's loss-of-function pathophysiology.

13. Prevention

No primary, secondary, or tertiary prevention strategies exist beyond genetic counseling and prenatal/preimplantation genetic diagnosis for known familial variants in families with an established diagnosis, given the Mendelian (dominant or recessive) inheritance pattern. No immunization, screening program, or public-health intervention is applicable to this monogenic skeletal/auditory disorder.

14. Other Species / Natural Disease

No naturally occurring CATSHL-like disease has been reported in veterinary/companion-animal or wildlife populations in the literature reviewed. All non-human data derive from engineered laboratory models (see Section 15) rather than spontaneously occurring animal disease. FGFR3 is highly conserved between human and mouse, supporting cross-species mechanistic relevance, but no OMIA (Online Mendelian Inheritance in Animals) entry for a natural CATSHL-equivalent condition was identified.

15. Model Organisms

Model	Genetic manipulation	Key phenotype	Reference
Mouse — conventional/conditional Fgfr3 knockout	Targeted disruption of Fgfr3	Skeletal overgrowth (elongated long bones and vertebrae), kyphosis/scoliosis, crooked tails; profound deafness due to failure of pillar-cell differentiation and tunnel-of-Corti formation; short lifespan in the constitutive knockout	Colvin et al. 1996, Nat Genet 12:390-397, PMID:8630492
Mouse — chondrocyte-specific conditional Fgfr3 knockout	Cre-lox conditional deletion in chondrocytes	Lengthened growth plates; significantly increased bone mass at 1 and 4 months; increased osteoblast number and bone formation; postnatal deletion produces chondroma-like lesions (enchondroma/osteochondroma) via decreased ERK/increased IHH signaling	Zhou et al. 2015, PLOS Genetics, doi:10.1371/journal.pgen.1005214
Zebrafish — CRISPR/Cas9 fgfr3 loss-of-function	Frameshift deletions in the tyrosine-kinase-domain-encoding exons (two independent stable lines)	Microcephaly, domed skull, delayed cranial suture closure, mandibular/hyoid deformity, delayed endochondral and intramembranous ossification, chondroma-like growth-plate lesions, dysregulated swim bladder/Weberian apparatus development, reduced scale mineralization; enhanced Wnt/β-catenin and IHH signaling; partial rescue with Wnt inhibitor XAV939	Sun X. et al. 2020, Theranostics 10(16):7111-7130, PMID:32641982
Mouse — activating Fgfr3 Y367C (reciprocal gain-of-function model)	Knock-in activating mutation (models Muenke syndrome/achondroplasia spectrum)	Hearing loss and inner-ear defects from excessive FGFR3 signaling — informative as the mechanistic mirror-image control for CATSHL's hearing phenotype	PMID:19073250

Phenotype recapitulation: The mouse and zebrafish Fgfr3 loss-of-function models recapitulate the core CATSHL triad of skeletal overgrowth, joint/growth-plate cartilage abnormality, and hearing impairment (via pillar-cell/organ-of-Corti defects) quite faithfully, and were instrumental in establishing FGFR3 loss-of-function as the causal mechanism — notably, the mouse phenotype was described a decade before the first human CATSHL family was reported, and the human discovery (Toydemir et al. 2006) explicitly drew on the mouse model to nominate FGFR3 as the candidate gene.

Model limitations: The zebrafish model captures craniofacial/microcephaly features not well recapitulated in mouse, but zebrafish skeletal architecture and organ of Corti biology differ substantially from human, limiting direct translational inference; mouse constitutive knockouts have reduced viability, complicating adult-phenotype study, motivating the shift to conditional/chondrocyte-specific models.

Applications: These models have been used to dissect the downstream signaling (MAPK/ERK, IHH/Hedgehog, Wnt/β-catenin) disinhibited by FGFR3 loss, and to test small-molecule pathway modulators (IHH inhibitors, XAV939) as proof-of-concept for future therapeutic strategies.

Summary of Key Evidence Citations

Toydemir RM, Brassington AE, Bayrak-Toydemir P, et al. "A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome." Am J Hum Genet. 2006;79(5):935-941. PMID:17033969.
Makrythanasis P, Temtamy S, Aglan MS, et al. "A Novel Homozygous Mutation in FGFR3 Causes Tall Stature, Severe Lateral Tibial Deviation, Scoliosis, Hearing Impairment, Camptodactyly, and Arachnodactyly." Hum Mutat. 2014;35:959-963.
Cannova S, et al. "CATSHL syndrome, a new family and phenotypic expansion." Clin Genet. 2024;105:313-316. PMID:37990933.
Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM. "Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3." Nat Genet. 1996;12:390-397. PMID:8630492.
Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. "Fibroblast growth factor receptor 3 is a negative regulator of bone growth." Cell. 1996. PMID:8601314.
Zhou X, et al. "FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling." PLOS Genetics. 2015. doi:10.1371/journal.pgen.1005214.
Sun X, et al. "Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling." Theranostics. 2020;10(16):7111-7130. PMID:32641982.
OMIM #610474 — CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME.
Orphanet ORPHA:85164 — Camptodactyly-tall stature-scoliosis-hearing loss syndrome.

Note on evidence gaps: No CATSHL-specific quality-of-life instrument data, no dedicated natural-history study, no CATSHL-specific clinical trial, and no naturally occurring veterinary disease model were identified — these represent open areas where the literature is silent rather than negative.

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	10
Resolved	9
Unresolved (possible confabulation)	1
Unverifiable	0
References weighed for topical relevance	9
On topic	6
Off topic	0

Unresolved references

These identifiers did not resolve to a record and may be fabricated. A lookup that failed for transport reasons is indistinguishable from one that failed because the record does not exist, so spot-check before acting on them:

DOI:10.1371/journal.pgen.1005214](https://journals.plos.org/plosgenetics/article (1 mention) - Identifier did not resolve to a record

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome	Count
Terms checked	38
Resolved	37
Unresolved (possible confabulation)	0
Obsolete	0
Unverifiable	1
Terms whose name was checked	16
Terms named correctly	8
Terms named as a different term	4
Terms whose name is worth a second look	4

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

CL:0002261 (1 mention) - the report calls it "Deiters' cell / cochlear supporting cell"; CL calls it endothelial cell of viscerocranial mucosa
UBERON:0002391 (1 mention) - the report calls it "cartilage of epiphysis / growth plate — approximate"; UBERON calls it lymph
UBERON:0004674 (1 mention) - the report calls it "organ of Corti / spiral organ"; UBERON calls it facial nerve root
UBERON:0002228 (1 mention) - the report calls it "rib cage / thoracic skeleton"; UBERON calls it rib

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

GO:0007173 (1 mention) - the report calls it "epidermal growth factor receptor signaling pathway analog"; GO calls it epidermal growth factor receptor signaling pathway
GO:0060445 (1 mention) - the report calls it "branching involved in salivary gland morphogenesis – not relevant"; GO calls it branching involved in salivary gland morphogenesis
GO:0005007 (1 mention) - the report calls it "fibroblast growth factor-activated receptor activity"; GO calls it fibroblast growth factor receptor activity, and lists "fibroblast growth factor-activated receptor activity" among its other names
GO:0043235 (1 mention) - the report calls it "receptor complex"; GO calls it signaling receptor complex, and lists "receptor complex" among its other names

Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: ORPHA.

Ask OpenScientist

OpenScientist Report

Classifications

Inheritance

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Prevalence

Differential Diagnoses

Experimental Models

Animal Models

Computational Models

Source YAML

References & Deep Research

References

Deep Research

CATSHL Syndrome (Camptodactyly, Tall Stature, and Hearing Loss Syndrome): Comprehensive Research Report

1. Disease Information

2. Etiology

3. Phenotypes

Core tetrad

Additional reported phenotypes

Phenotype characteristics

4. Genetic/Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

Molecular pathway and causal chain

Hearing loss mechanism

Causal chain summary

Suggested ontology terms

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome/Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Summary of Key Evidence Citations

Reference Validation

Unresolved references

Term Validation

Terms the report names something else

Terms whose name is worth a second look

Prefixes with no resolver